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Eukaryotic elongation factor 2 kinase (eEF-2K) is a calmodulin (CaM)/calcium 
regulated kinase whose activity disrupts translation elongation resulting in the global 
decrease of protein synthesis1. Translation is one of the most energy intensive processes 
in a cell; eEF-2K is critical in maintaining cellular homeostasis. The dysregulation of 
eEF-2K is associated with an assortment of diseases including several types of cancer2, 
depression3,4, and Alzheimer’s disease5, which has prompted closer examination across 
multiple studies of the enzyme in recent decades. Notably, the kinetic mechanism of eEF-
2K has been detailed as a two-step process: 1) The binding of Ca2+-CaM enables the 
autophosphorylation of Thr-348 and 2) The resulting conformational change enables 
eEF-2K to bind and phosphorylate its substrate. We have uncovered many surprising 
layers of eEF-2K regulation in past years, from kinetic mechanism to upstream affecters 
to models of CaM binding. This study focuses on the role of pH in regulating eEF-2K. 
pH homeostasis is also vital for cellular function. Even a slight disruption 
between the intra- and extracellular pH ratio can affect an array of processes such as ATP 
synthesis, enzyme function, as well as the proliferation, migration, and invasion of tumor 
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cells6. Acidosis is a common effect of high intensity exercise, diabetic ketoacidosis, 
ischemia, and solid tumors7–9. It has been demonstrated that eEF-2K activity is increased 
and protein translation decreased in cells under acidic conditions, suggesting the 
enzyme’s potential cytoprotective effects10–12.  
This work reports the following: 1) A novel mechanism where H+ instead of Ca2+ 
activates eEF-2K; 2) A novel mechanism where H+ can replace Ca2+ in promoting eEF-
2K substrate phosphorylation; 3) H+ promotes the binding of CaM to eEF-2K in a Ca2+-
independent manner; 4) There are five histidine residues on eEF-2K that may contribute 
to the stabilized activity of eEF-2K under acidic conditions. 
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 1 
Chapter 1: Introduction 
 
1.1. OVERVIEW 
There are approximately 518 genes in the human genome, roughly 2% of all 
human genes, corresponding to protein kinases13. These enzymes stabilize the transfer of 
phosphate from a high-energy molecule, such as ATP or GTP, to their corresponding 
protein substrates. Typically this covalent modification occurs on amino acids with a free 
hydroxyl group, most commonly serine, threonine, tyrosine, and less commonly 
histidine14,15. 478 protein kinases are classified into seven main groups based on the 
sequence similarity of their catalytic domains. eEF-2K (EC: 2.7.11.20) is included with 
the 40 remaining enzymes in the 8th group, ‘atypical’ kinases, which have do not share 
sequence homology with their counterparts13,16,17. 
Up to 30% of human proteins are predicted to be phosphorylated by kinases18. 
Phosphatases are enzymes that remove covalent phosphorylation which makes this post-
translational modification reversible, a characteristic that is useful in the context of 
protein regulation. Indeed, kinases are known to play important roles in cellular processes 
including proliferation, cellular differentiation, morphogenesis, survival, transcription, 
metabolism and more1,3,19. 
 
1.2. PHYSICAL CHARACTERIZATION OF ELONGATION FACTOR-2 KINASE  
In order to begin to understand and characterize eEF-2K, it is critical to have a 
reliable and consistent enzyme form. In 1985 when eEF-2K was a novel protein and 
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before its sequence was mapped and reported, the kinase was isolated from rat pancreas 
and rabbit reticulocytes for study20,21. Because it was purified from living tissue, the 
multisite regulatory phosphorylations weren’t homogenous, yields were low and as we 
now know had comparatively low activity22,23. Still, this form was sufficient to provide 
initial kinetic analysis and to begin identifying upstream regulators24–28. The 1996 
sequencing and cloning of rat muscle eEF-2K cDNA was the start of understanding eEF-
2K structure, and the 1999 bacterial expression and purification of GST-tagged eEF-2K 
was the standard for studying eEF-2K until our 2011 tagless human recombinant enzyme 
purification29–31. The main drawbacks of pre-2011, or studies still using GST-tagged eEF-
2K is this form tends to oligomerize, skewing experimental results, and is significantly 
less active than our optimized purification30–32.  Our purification strategy was novel in 
that we coexpressed with λ-phosphatase in order to homogenize the phosphorylation 
state, we used a specialized bacterial strain (Rosetta-gami (DE3)) to accommodate the 
high proportion of rare codons, our purification involved three column purifications in 
sequence (initial Ni-NTA affinity, anion-exchange to further clean, and gel filtration size 
exclusion to remove any dimers) and we yielded milligram amounts of enzyme per 
purification batch (2-6L)31.  
There is still yet to be a successful report of a three-dimensional eEF-2K structure 
as it has been notoriously difficult enzyme to obtain a crystal structure or NMR analysis 
for, likely in part due to the ~150 amino acid loop located in the middle of the enzyme33. 
Over the years, however, a compilation of many studies has led to a model for the 
structure and organization of eEF-2K. 
 3 
1.2.1. Homology Studies of eEF-2K  
eEF-2K was initially identified by its substrate eEF-2 (then known as a 
100,000kDa protein) and was reported as Ca2+/CaM-dependent protein kinase III 
(CaMK-III) as the study reported it requiring both Ca2+ and CaM to be active20,34–36. 
While there is a Ca2+/CaM-dependent kinase (CAMK) family of protein kinases, eEF-2K 
does not share sequence similarity with them.  
Modern kinases are classified into 11 groups, 134 families and 196 subfamilies 
primarily based on kinase domain similarity and also additional domain similarities, 
evolutionary conservation and function similarity13,37,38. Traditionally, kinases can be 
separated 90% into the superfamily eukaryotic protein kinase (ePK) and the remaining 
10% into ty protein kinases (APK) which represent the protein kinases that lack of 
sequence homology to ePKs16,17,39. More recently the APK group has been split to 
accommodate new protein sequences. eEF-2K, upon its initial sequencing, was classified 
as atypical protein kinase but now belongs to the PKL group, characterized by a protein 
kinase like fold and similar catalytic mechanisms40,41. The PKL family known as alpha 
kinases are unique to eukaryotes as they appeared relatively recently in evolution; eEF-
2K is actually classified as an alpha protein kinase, the only CaM/Ca2+ dependent kinase 
in this family. Subfamilies of alpha kinases have very different domain structures but are 
defined by a catalytic domain homology to the myosin heavy chain kinases 
(MHCK)16,17,42. The alpha kinases are so named as many target substrate residues within 
an alpha-helix conformation43,44.  
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Apart from the MHCK proteins, a well-studied alpha kinase is TRPM7 kinase of 
the TRP ion channel family (48, 49).  The solved crystal structure of the TRPM7 kinase 
domain in 2001 greatly helped shape our understanding of alpha kinases; despite the lack 
of sequence homology the final structure has similarities to the conventional protein 
kinase (CPK). The similarities to CPKs that TRPM7 demonstrated include: 1) a  β-sheet 
N-terminal lobe containing a phosphate-binding loop; 2) an ATP-binding inter-lobe 
catalytic cleft; 3) a propensity to contain C-terminal α-helices and an activation loop. 
Differences include: 1) differences in C-terminal structures; 2) binding mode of ATP; 3) 
location of the glycine-rich motif ; and 4) presence of a zinc-finger in the C-terminus of 
alpha-kinases16,45. These homology studies laid the groundwork to our current 
understanding of eEF-2K domain and structure45–47. 
 
1.2.2. eEF-2K Domain Organization  
The current proposed domain organization of eEF-2K is summarized in Scheme 
1.1. The studies defining this primarily used primary sequence alignment, mutational 
studies, and homology studies of alpha-kinase crystal structures MHCK and TRPM730,48.  
Reviewing the structure starting at the N-terminus: there is an aspartic acid-heavy 
DXDXDG motif at amino acids 24-29 that is a potential Ca2+ binding domain (CRD) 
whose role is currently unknown49. This is shortly followed by a inhibiting regulatory 
phosphorylation site, Ser-78, and residues 79-96 contain a calmodulin (CaM) binding 
domain (CBD) that is critical for activation. Specifically, residue Trp-85 is suggested to 
be a critical part of CaM binding and kinase activity, perhaps as a result of the former50. 
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The atypical α-kinase catalytic kinase domain (KD) of eEF-2K spans from residues 116-
326, which is located more towards the N-terminus compared to other atypical 
kinases30,48.  In the kinase domain there are four conserved residues critical for kinase 
activity; the corresponding residues in TRMP7 function for the coordination of a Zn2+ 
ion51 which suggests the possibility of a Zn2+ ion to be necessary for eEF-2K catalytic 
activity. There are several other elements involved in the catalytic domain and ATP 
coordination: 1) Between residues 296-301 is a glycine rich loop GXGXXG which is 
involved in ATP localization16; 2) Lys-170 interacts with the α- and β-phosphates of ATP 
to stabilize its binding; 3) Asp-284 is part of the conventional DFG (DPQ in eEF-2K) 
motif and is involved in chelating the Mg2+ ion that helps orient and coordinate ATP; 4) 
Glu-299 and Thr-283 form a hydrophobic pocket for ATP; 5) Asp-274 acts as a catalytic 
base; and 6) Lys-205, Arg-252, and Thr-254 form a phosphate binding pocket which 
binds autophosphorylated Thr-348 and promotes for allosteric activation of eEF-
2K16,52,53.   
The linker region of eEF-2K, residues 327-477, form a regulatory loop (R-loop) 
that carries four of the main regulatory phosphorylation sites (Thr-348, Ser-359, Ser-366, 
and Ser-398) as well as a 440DSGXXS445 degron motif (DM). The diphosphorylation of 
the serine residues in this motif is involved in the recognition of eEF-2K by the SCFβTrCP 
ubiquitin ligase. This event prompts degradation of eEF-2K and adds another layer of 
eEF-2K regulation and translational control54–56. Autophosphorylation of Thr-348 and its 
subsequent binding to the abovementioned phosphate binding pocket in the kinase 
domain is a prerequisite for kinase activity54,57.  
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After the linker region there is the C-terminal lobe, residues 478-725 that is 
comprised of three helical SEL1-type domains (SHR), which are typically known to be 
involved in protein-protein interactions, and a C-terminal tail that interact with the KD. 
This region is necessary for substrate phosphorylation but not intrinsic activity which 
implicates a role in substrate interaction although it has been suggested that the extreme 
C-terminal domain of eEF-2K is not a primary eEF-2 docking site on its own33,58. 
Knowing all of this information about eEF-2K domain organization is important 
understanding its various physiological contexts.  
 
1.3. PHYSIOLOGICAL CONTEXT OF EUKARYOTIC ELONGATION FACTOR-2 KINASE  
Eukaryotic elongation factor 2 kinase (eEF-2K) is a calmodulin (CaM)/calcium 
regulated kinase whose activity disrupts translation elongation resulting in the global 
decrease of protein synthesis1. Translation is one of the most energy intensive processes 
in a cell; eEF-2K is critical in maintaining cellular homeostasis. The dysregulation of 
eEF-2K is associated with an assortment of diseases including several types of cancer2, 
depression59, and Alzheimer’s disease5.  
 
1.3.1 Translational Control and Energy Regulation  
 The translation of mRNA into amino acids is a highly regulated process that 
occurs in three steps of initiation, elongation, and termination. It was first believed that 
initiation was the primary point of regulation however the 1980’s discovery of eEF-2K 
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led to the studies suggesting elongation is a critical point of protein synthesis1. There are 
three elongation factors that assist the tRNA and growing polypeptide chain through the 
A, P and E sites of the ribosome (Scheme 1.1). Elongation factor-1 alpha (eEF-1a) is 
responsible for recruiting aminoacyl-tRNA (aa-tRNA) molecules to the A site of the 
ribosome. Upon a successful codon-anticodon match eEF-1a catalyzes GTP hydrolysis 
finalizing the binding of the aa-tRNA to the ribosome60. Elongation factor 2 (eEF-2) is 
responsible for the translocation of the tRNA from the A site to the P site after the newest 
peptide bond has formed; this translocation is also a GTP-dependent step61. Elongation 
factor 3 (eEF-3) is not present in all eukaryotes but associates with the E site of the 
ribosome and has various suggested functions including the catalysis of the ATP-
dependent release of the tRNA from the ribosome and the assistance of eEF-1a in aa-
tRNA recruitment62. In this way each protein requires a minimum of two ATP/GTP per 
amino acid to be synthesized, which is why translation is so energy intensive. Many of 
the translation factors’ activities are modulated via phosphorylation, allowing for precise 
control over protein synthesis rate and related energy expenditures63.    
 In particular, the only known substrate of eEF-2K (82kDa) is eEF-2 (100kDa). 
eEF-2K phosphorylates eEF-2 at Thr-56 thereby inhibiting its activity; it has been 
suggested that a decreased affinity to the ribosome is the cause behind this inhibition34,64–
66. There are a number of factors that can alter the rate or protein synthesis utilizing this 
schematic alone including: amount of active vs. inactive eEF-2K, amount of ribosome-
bound eEF-2 (which is protected from phosphorylation)67,  as well as post-translational 
modifications on both eEF-2K (which alter its activity) and eEF-2 (which alter the rate 
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and amount of Thr-56 phosphorylation). Examples include cyclin A-CDK2 which 
recruits eEF-2K by phosphorylating eEF-2 at Ser-535 and protein phosphatase 2A 
(PP2A) which is associated with eEF-2 dephosphorylation68. Post-translational 
modifications affecting eEF-2K activity will be discussed in the next section with the 
contexts in which they occur.  
 With this in mind, there is already a flexible and complex balance between eEF-
2K and eEF-2 activity and all of their regulators. eEF-2K adds a further layer of delicate 
orchestration as it is known to induce translation of select transcripts69–71, despite its 
typical effect of global downregulation of protein synthesis.   
 
1.3.2 eEF-2K in the Cell Cycle 
In every actively replicating cell type it is vital to control the progression, and 
protein synthesis along with it, through the cell cycle. During the G1 phase, protein 
synthesis is important to build up and essentially double the size of the cell; eEF-2K must 
be inactivated for this to happen. This occurs through the inactivating phosphorylations 
on Ser-359 and Ser-366, which are downstream of cdc2 kinase (a cyclin-dependent cell 
cycle regulator) and the growth factor and nutrient activated mitogen-activated protein 
kinase kinase/extracellular signal-regulated kinases (MKK/ERK), mammalian target of 
rapamycin/S6 kinase 1 (mTOR/S6K1) pathways (Scheme 1.2)72–74. As the cell cycle 
progresses, this inhibition of eEF-2K must be alleviated to halt protein translation so the 
cell may progress into the DNA synthesis S phase and proofreading/cell division G2/M 
phase. This is likely accomplished by 1) an eEF-2K-activiting rise in cAMP, thereby 
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activating PKA which targets the activating phosphorylation site Ser-500 on eEF-2K, 2) 
Ca2+ levels, which stimulate CaM binding to eEF-2K, as well as 3) phosphatase-removal 
of inactivating phosphorylations75,76. The current model of mechanism behind the 
activating Ser-500 phosphorylation is in part the generation of Ca2+ independent activity 
of eEF-2K; CaM is still required for this activity. Phospho-Ser-500 has been also been 
shown to increase eEF-2K affinity for Ca2+-bound CaM and apo-CaM and is associated 
with increased catalytic activity against the eEF-2K peptide-substrate36,53,77.  In vitro 
studies have also shown that PKA can phosphorylate Ser-366 on eEF-2K but this site was 
not significant in in vivo studies.  
Additionally, eEF-2K is known to be phosphorylated at Ser-78 by transient 
receptor potential cation channel, subfamily M, member 7 (TRPM7), a channel-kinase 
that regulates Mg2+ homeostasis (a process tied to cell growth)78,79. Ser-78 is generally 
known to be an inhibiting site of phosphorylation; the mechanism behind its effect on 
eEF-2K activity requires further study80. This phenomenon also goes to speak to the 
intricate web that is regulation by eEF-2K multi-site phosphorylation.  
 
1.3.3. eEF-2K and Cell Stress 
 eEF-2K has been implicated in several types of cell stress, including hypoxia,  
autophagy, nutrient deprivation and endoplasmic reticulum (ER) stress81–87. The 
activation of eEF-2K and global downregulation of the energy-consuming protein 
synthesis allows the cell a chance to reestablish homeostasis.  
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 Hypoxia: Hypoxic stress occurs for a variety of cellular processes and diseases 
including embryogenesis, would repair, high intensity exercise, heart disease, stroke, 
diabetes and cancer88. Under hypoxic conditions, cells cannot undergo oxidative 
phosphorylation to produce ATP and so are in a state of energy shortage and 
conservation. Hypoxia is known to lead to inhibition of protein synthesis by activating 
eEF-2K in a number of ways: a) Activation of the energy sensing protein AMP-activated 
kinase (AMPK) which activates eEF-2K by inhibiting its inhibitors; AMPK 
downregulates both ribosome-associated kinase p70S6K and mammalian target of 
rapamycin (mTOR) which phosphorylate and inhibit eEF-2K on Ser-36689. mTOR is 
additionally known to phosphorylate and inhibit eEF-2K on Ser-78 and Ser-35974,90,91. In 
vivo AMPK activity has also been correlated to a rise in phosphorylated Ser-398 on eEF-
2K in cells, a site that was proposed to potentially increase activity by increasing the 
affinity of eEF-2K to CaM90. The mechanisms behind this and the Ser-359 and Ser-366 
inhibitory phosphorylations are still unclear and require further validation, although it is 
hypothesized that based on location the Ser-78 phosphorylation may act in affecting CaM 
binding90. b) Activation of the hypoxia inducible factors HIF-1α/β which leads to the 
inactivation of mTOR, once again alleviating this source of eEF-2K inhibition92.  
 Nutrient Deprivation: Metabolic stress occurs in situations of nutrient deprivation 
such as inadequate blood circulation and solid tumors. This puts the cell in a state of high 
energy demand and conservation similar to hypoxia. eEF-2K is also activated under 
similar mechanisms; 1) AMPK responds to a drop in the ratio of ATP:ADP, activating 
eEF-2K via mTOR inhibition and potentially the activating Ser-398 
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phosphorylation5,90,93,94. 2) mTOR is directly regulated by ATP and amino acid 
availability- its inacivation is in part through AMPK and ultimately leads to higher eEF-
2K activity5,92. 3) 95,96. 
 Endoplasmic Reticulum Stress: ER stress is a collection of issues such as 
ischemia, ER Ca2+ depletion, hypoxia, and oxidative stress. Together the result is an 
accumulation of unfolded or misfolded proteins which initiates the cell’s unfolded protein 
response (UPR) which results in either regained homeostasis or initiation of apoptosis97. 
eEF-2K is activated under ER stress to slow down the synthesis of new proteins and 
decrease the load on the ER 98. AMPK is a prominant pathway activated during ER 
stress, and it is likely that this is the mechanism through which eEF-2K is regulated89,97.   
Other Stress: eEF-2K has been shown to be downstream of the stress-activated 
protein kinase 4 (SAPK4), also known as  the mitogen-activated protein kinase p38δ 
(MAPK13)99. This protein serves as a stress response to stimuli such as inflammatory 
cytokines, ultra-violet radiation, growth factors, endotoxins and osmotic shock. 
SAPK4/p38δ activity has been correlated with eEF-2K phosphorylation on Ser-359, an 
inhibitory site of regulation, and Ser-396 which in combination decrease eEF-2K activity 
by 80%74,100. It is interesting that SAPK4/p38δ responds to both stress conditions that 
could be expected to increase eEF-2K activity as well as growth factors where it is 
logical to increase eEF-2 activity and is ultimately correlated with inhibitory 
phosphorylations on eEF-2K. This is an example of why and how eEF-2K must 
orchestrate its myriad of regulatory phosphorylations into a coherent output of activity 
level that is ultimately beneficial to the current cellular state.  
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Autophagy: When a cell is overwhelmed by an accumulation of stressors that are 
too much to process, the balance of singalling processes tip towards cell death rather than 
striving towards homeostasis. Autophagy often includes a variety of cell stresses we have 
discussed up until this point, and reports have shown that eEF-2K is required to mediate 
autophagy through these pathways and mechanisms85,87,101,102.  
 
1.4. IMPLICATIONS OF EEF-2K IN DISEASE 
1.4.1. Significance in Cancer 
We have discussed the involvement of eEF-2K in stress responses involving 
hypoxia, autophagy, ER stress and nutrient deprivation. These are all hallmarks of tumor 
cells, and so it makes sense that dysregulation of eEF-2K during these processes has been 
tied to cancer. Since 1999 eEF-2K has been implicated in having various supportive roles 
in several types of cancer including breast cancer, pancreatic cancer and 
glioblastoma87,101,103. Upregulated activity of the enzyme has been correlated to 
cytoprotection, increased survival, as well as enhanced proliferation and invasion of 
tumors104–107. Even before eEF-2K was specifically implicated, Rosenwald et al. 
demonstrated transient inhibition of protein translation induced the expression of proto-
oncogenes and stimulation of cells into an active mitotic state108. Elevated levels of eEF-
2K have been associated with poor prognosis for hepatocellular cancer, medulloblastoma 
and glioblastoma109,110.  
Studies on eEF-2K and breast cancers have demonstrated its overexpression in 
several breast cancer cell lines and that siRNA knockdown of the enzyme inhibits 
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proliferation and invasive properties while inducing apoptosis109. A similar in vivo study 
confirmed that an eEF-2K knockdown in an orthotopic xenograft of human breast cancer 
in a mouse model results in decreased growth and increased anti-cancer drug 
sensitivity111.  
Its relationship to various cancers provides a compelling platform for the study of 
eEF-2K and has resulted in novel mechanism discoveries. Still, there is much more to 
study and investigate regarding its potential therapeutic inhibition and underlying 
mechanisms in promoting tumor health. 
 
1.4.2. Significance in Neuronal Processes and Diseases 
 Neurons are known for the speed of their communication and their vast signaling 
network. They accomplish this by with propagated electric pulses and ion gradients that 
are initiated by neurotransmitters. Different types of neurotransmitters elicit different 
types of signals/electric pulses that can vary in frequency and amplitude. Ca2+ is a widely 
used ion in the generation of these signals, which is how eEF-2K became implicated in 
neuronal processes such as synaptic plasticity, learning and memory112–114. eEF-2K must 
interpret and integrate calcium oscillations into its activity output and control of protein 
translation115. Synaptic plasticity refers to the ability of synapses to strengthen (quickly 
transmit signals) or weaken over time as a response to how often they’re utilized, and is 
believed to be the mechanism behind learning and memory113,116–118.  
 Studies involving eEF-2K in neurons have demonstrated that while eEF-2K 
downregulates global protein synthesis, select transcripts are upregulated in dendrites. 
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Upregulated transcripts are all proteins implicated in the modification of synapses and 
include the alpha subunit of Ca2+/CaM-dependent protein kinase II (αCaMK-II)117, 
microtubule-associated protein 1B (MAP1B)119, activity-regulated cytoskeletal-
associated protein (Arc)71, brain-derived neurotrophic factor (BDNF)69, and AMPA 
receptors120. Such a phenomenon had not been previously observed and the mechanism 
behind this location-specific translation is unknown.  
 Due to the involvement of eEF-2K in neuronal processes it follows logically that 
its dysregulation can impact neuronal diseases. Indeed, eEF-2K has been implicated in 
depression, as studies have shown that eEF-2K is a critical mediator of the antidepressant 
effect of the rapid-acting drug ketamine, and Alzheimer’s, where reports show increased 
eEF-2 phosphorylation4,98,121–125. Unfortunately these effects of eEF-2K in neuronal 
disease are not widely studied and remain poorly understood. 
 
1.5. REGULATION OF ELONGATION FACTOR-2 KINASE BY CALCIUM AND 
CALMODULIN 
1.5.1. Intro to Calcium and Calmodulin 
Calcium ions are universally utilized in various signaling events, usually 
involving rapid oscillations and spikes in concentration and requiring highly efficient ion 
channels and stores126. Resting cytoplasm Ca2+ concentrations are maintained around 
100nM, 20,000-100,000 times lower than the extracellular or organelle concentration127. 
Cells are capable of releasing, maintaining, and retracting varying times and 
concentrations of Ca2+ spikes. During a calcium signal, cytoplasmic Ca2+ can rapidly rise 
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utilizing concentration gradients; time and location of this signal can be tightly controlled 
with Ca2+-binding proteins and Ca2+ pumps that return ions to the extracellular matrix or 
organelle stores128–131.  
Calmodulin (CaM) is the primary protein used to interpret these various Ca2+ 
signals, and is specialized to eukaryotes128. CaM structure is well studied; it is a 16kDa 
protein, typically dumbbell shaped. The two lobes of the dumbbell are each composed of 
two EF-hands which cooperatively bind a Ca2+ ion albeit with varying affinity. The C-
terminal Ca2+ binding sites have an affinity (Kd) towards Ca2+ that range from 500nM to 
5µM, which is 3-5 times higher than the N-terminal sites128. The lobes are separated by a 
flexible linker that is critical in conveying allosteric changes with each ion binding132.  
CaM is such a central and critical protein to cellular function that it has been 
suggested to make up 0.1% of total proteins in the cell, with cytoplasmic concentrations 
ranging from 2-25µM128,133. Furthermore CaM binds many proteins, over 100 distinct 
targets, with varying specificity and effects- with each Ca2+ ion bound it has a different 
conformation and therefore each state has a different affinity for its many substrates. 
CaM has been known to bind irreversibly independent of Ca2+ concentrations, it has been 
known to change affinity on the same complex based on Ca2+ levels and there are 
examples of CaM both inhibiting and activating kinases126,128. An additional perspective 
to consider is the free CaM concentration which can range from 10pM to 10µM because 
of the targets that CaM is binding to at any given point128,134.  
A study released in 2012 by our lab demonstrated that in the presence of 
saturating CaM (2µM), eEF-2K is barely active when free calcium concentrations are at 
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25nM and fully active at [Ca2+]free = 3 µM; we calculated the Kd for free Ca2+ at 
140nM135. We also did a study using phosphate-free enzyme in measuring CaM affinity 
as other reports used various forms of post-translationally modified eEF-2K which have 
varying affinities for CaM. Our lab reported a Kd for fluorescently labeled Ca2+/CaM 
around 25nM53. These findings are in line with the idea that the enzyme responding to 
calcium signals and oscillations; at resting intracellular levels of calcium eEF-2K should 
have little activity which is enhanced by raised Ca2+ levels. It is important to note, 
however, that a study in cells reported that transient Ca2+ influxes are sufficient to induce 
eEF-2 phosphorylation but insufficient in affecting global translation136.  
Studies have confirmed that the roles of Ca2+ and CaM in regulating eEF-2K are 
promoting autophosphorylation of eEF-2K at Thr-348 and Ser-500, promoting efficient 
substrate phosphorylation, and (for CaM) ultimately allowing for continued activity of 
eEF-2K in the absence of Ca2+ 20,35,36,54,137,138. Our data (chapters 2-3) have shown a novel 
mechanism for a calcium-independent mechanism of eEF-2K via acidic conditions, 
which would provide an additional layer of physiological regulation to help explain the in 
vivo functions of eEF-2K. 
 
1.5.2 Binding Interaction between eEF-2K and Calmodulin 
A full crystal structure for eEF-2K has not successfully been defined however 
recently a group has resolved the structural binding details of CaM with an eEF-2K 
truncation mutant. Given CaM’s integral role in eEF-2K activation and activity, studying 
the nature of the interaction between CaM and eEF-2K can give us massive insight into 
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understanding the nature of regulation on eEF-2K by CaM. This study employed a 
number of methods, including mass spectrometry, small angle x-ray scattering, NMR and 
computational modeling, to gain insight to eEF-2K conformation and binding to CaM. 
In other CaM regulated kinases, CaM binding causes a conformational 
rearrangement of a substrate-like-moiety away from the substrate recognition site in a 
method referred to as the release-of-inhibition mode of activation53,139,140. eEF-2K does 
not operate in this manner; instead the study demonstrated that with each step of CaM 
binding, i.e. during activation and substrate phosphorylation, there is a favorable change 
in conformation allowing for either autophosphorylation or substrate interaction139. In 
other words, the eEF-2K conformational change results in increased in intrinsic 
activity/ability to phosphorylate rather than an increase in substrate affinity, which does 
not significantly change upon CaM binding53.  
This study also unexpectedly reported that even in high calcium concentrations 
CaM binds eEF-2K with only two Ca2+ ions bound in the N-terminus. This Ca2+-loaded 
region of CaM only forms sparse and weak interactions with eEF-2K on sites distinct 
from the calmodulin-binding domain (CBD)126,141,142. Furthermore it is the Ca2+-free C-
terminus of CaM that binds the CBD of eEF-2K; the conserved W85 residue on eEF-2K 
inserts deep into a hydrophobic cavity on CaM.. 
While CaM is required for eEF-2K activation and substrate phosphorylation, 
these events have been observed to occur under in its absence, though it is on the 
timescale of minutes to hours instead of seconds54. Apart from the CaM structure 
discussed earlier, it is important to note that it has been demonstrated that H+ ions have 
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the capability of promoting a similar conformational change in CaM similar to Ca2+ 
binding142,143. Based on this study our hypothesis and working model suggests that 
protons supplement Ca2+ in favorably altering CaM concentration to bind eEF-2K- we 
confirm this in Chapter 4.  
 
1.5.3. Autophosphorylation of eEF-2K by Calcium and Calmodulin 
Thr-348: Upon its discovery eEF-2K was initially referred to as Ca2+/CaM-
dependent protein kinase 3 (CaMK-III) because it was identified as needing Ca2+/CaM to 
exhibit activity10,144,145. It was later discovered that Ca2+/CaM is necessary for initial 
autophosphorylation of Thr-348 which represents the first step in activation (Scheme 1.2) 
and although eEF-2K can exhibit Ca2+-independent activity CaM remains constantly 
critical 36,52–54,135,146. Under saturating conditions the rate of Thr-348 autophosphorylation 
is extremely rapid, occurring at a rate of 3 s-1 54. Truncation studies have revealed the 
mechanism of activation behind Thr-348: this site is located on the regulatory loop (R-
loop) and its Ca2+/CaM induces autophosphorylation by stabilizing the appropriate 
conformation.  This autophosphorylated form of eEF-2K promotes binding to a 
conserved hydrophobic pocket, formed by Lys-205, Arg-252, and Thr-254, near the 
catalytic domain which in turn promotes substrate binding54. Phosho-Thr-348 also 
allosterically promotes the autophosphorylation of Ser-50036,135.  
Ser-500: Ser-500 is located in the SHR domain of eEF-2K (Scheme 1.1) and is a 
site of activating phosphorylation. It can be autophosphorylated after activation (Thr-348 
autophosphorylation) and is also known to be phosphorylated externally via PKA and the 
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cAMP pathway36,53. The mechanism resulting in increased eEF-2K activity is increasing 
the enzyme’s affinity for Ca2+ bound CaM as well as apo-CaM (Ca2+-free form). This is 
significant because it was the first instance of Ca2+-independent activity observed of eEF-
2K, which could be an explanation of the location-specific activity of eEF-2K seen in 
neuronal cells30,147. Ser-500 phosphorylated enzyme also shows increase substrate 
phosphorylation, possibly as a result of increased CaM sensitivity36,53,135.  
 
1.6. SUMMARY OF THE MULTI-SITE PHOSPHORYLATIONS OF ELONGATION FACTOR-
2 KINASE  
We have discussed the various phosphorylation sites of eEF-2K in the context of 
the conditions where they occur, and here we accessibly summarize the various site and 
their possibilities (Scheme 1.1). The types of phosphorylations that can occur are 
activating, inhibiting and degradation-promoting and they can occur either by 
autophosphorylation or via upstream kinases. The many phosphorylation sites mentioned 
above provide a flexible and multi-input method for the cell to fine-tune eEF-2K activity, 
and mechanism behind the effect for many of them are believed to be associated with 
enhancing or diminishing the enzyme’s affinity to CaM.  
Activating phosphorylations of eEF-2K typically occur under situations of stress 
where it is helpful to conserve energy and direct resources towards establishing 
homeostasis. Examples of stress include hypoxia, nutrient deprivation and endoplasmic 
reticulum stress; upstream pathways that activate eEF-2K include elevated Ca2+ levels 
and the AMPK and PKA pathways. Activating phosphorylation sites include Thr-348, 
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Ser-500, and Ser-398. Thr-348 and Ser-500 are autophosphorylation sites and Ser-500 
and Ser-398 are phosphorylated by other kinases.  
Inhibiting phosphorylations of eEF-2K are typically promoted by situations of 
cell growth and proliferation where it’s important to have full protein synthesis. 
Inhibition of eEF-2K can occur when Ca2+ levels are too low to facilitate CaM binding or 
with mTOR, MAPK (MEK/ERK), cdc2-cyclin B, p38δ, p70S6K and p90RSK1 
activities74,80,95,100,148. Inhibiting phosphorylation sites include Ser-78, Ser-359, Ser-366 
and Ser-396; the first three can be autophosphorylated after Ca2+/CaM stimulation and all 
four can be phosphorylated via the upstream pathways80,149. These autophosphorylations 
incorporate relatively slow compared to the activating autophosphorylations of Thr-348 
and Ser-50052,135. It is hypothesized that Ser-78, Ser-359 and Ser-366 may function to 
inhibit CaM rebinding after it dissociates from eEF-2K although additional studies are 
required to validate these postulations36,141,150.  
Degradation-promoting phosphorylation sites are located at Ser-441 and Ser-445 
in the degron motif 440DSGXXS445 at the end of the R-loop on eEF-2K55,151. A study in 
2005 was the first to report eEF-2K ubiquitination and regulation by degradation, later 
reported to be carried out via the ubiquitin ligase SCFβTrCP151,152. There are several 
hypotheses of the mechanism behind when eEF-2K degradation is initiated: 1) eEF-2K 
has been reported to associate with the chaperone heat shock protein Hsp90, which 
protects eEF-2K from ubiquitination. eEF-2K synthesis and degradation may exist in a 
balance between Hsp90 stabilization of eEF-2K over time. 2) Several studies have 
suggested that Ser-398 and Ser-500 phosphorylation promote proteasome degradation of 
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eEF-2K. It is postulated that as these phosphorylations enhance CaM affinity and as 
degradation is decreased in the eEF-2K W85S mutant (has lower CaM affinity), CaM 
binding may cause a conformational change that promotes autophosphorylation of the 
degron motif36,141,153.  
 
1.7. REGULATION OF ELONGATION FACTOR-2 KINASE BY ACIDITY 
An additional form of eEF-2K regulation that has been proposed is pH154. 
Common physiological events involving intracellular pH fluctuations include gamete 
activation and fertilization, cell cycle, and stimulation by mitogens and growth 
factors155,156. Cytoplasm acidification has been correlated to global protein synthesis 
suppression and occurs under stress conditions such as ischemia, hypoxia, high intensity 
exercise, diabetic ketoacidosis, and solid tumors7–9,81,157. Tight control of pH homeostasis 
is vital to cellular function as many processes have evolved to operate at the narrow 
physiological range (typically 7.2-7.5) and movement outside of this range can cause 
dysregulation158. Several studies have demonstrated that acidic conditions are activating 
to the enzyme however there has been no in depth kinetic study to explain this 
effect11,154,159. Nairn et al10 first connected eEF-2K activation to acidity, Xie et al12 looked 
into this activation by various signaling pathways, and Dorovkov et al11 demonstrated an 
in vitro increase in maximum rate at low pH. A more thorough kinetic evaluation is 
important for providing insight into how pH affects eEF-2K activity aside from upstream 
signaling, for example increased efficiency of activation, CaM binding or intrinsic 
activity.  
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Acidity has also been tied to calmodulin, which is necessary for eEF-2K 
activation and activity as described above. Calmodulin has four Ca2+ binding sites that 
trigger a conformational change that in turn regulates its binding properties and relays 
calcium signals to CaM-binding proteins126,143. Low pH has been demonstrated to affect 
CaM structure and binding similarly to calcium which would likely affect eEF-2K 
activation143.  
Here we report more definitive kinetic mechanisms where acidity appears to 
enhance increase the affinity of Ca2+-CaM as well as apo-CaM, resulting in increased rate 
of autophosphorylation (activation) and substrate phosphorylation (intrinsic activity) that 
is particularly apparent in the absence of Ca2+ (Chapters 2-4). Because histidine residues 
are known to ionize in the pH 6 range we additionally use mutational studies to identify 
His-103, His-201, His-227, His-230 and His-288 as potential histidine residues that are 
critical for the partial mitigation of this activation via H+ ion.  
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Scheme 1.1. Summary of eEF-2K domains and regulatory phosphorylation sites.  
(Figure adapted from Chapter 4). Between CaM/Ca2+ control and the various possible 
phosphorylation states (colored circles; green for activating and red for inhibiting) it is 
clear that there are many layers to eEF-2K regulation that allow the complex integration 
of cellular signals. Current studies suggest that CaM binding acts as an on/off binary 
switch while the phosphorylation sites act in combination through various mechanisms to 
determining the level of activity54. Of the phosphorylation sites discussed here, T348 and 
S500 are autophosphorylated upon Ca2+/CaM stimulation (light blue outline)135, S398 is 
phosphorylated by AMPK under energy stress90, and S500 can be additionally 
phosphorylated by cAMP-dependent protein kinase (PKA)138; these three sites are 
activating. On the other hand, mTOR, via downstream kinases, phosphorylates the three 
inhibitory sites: S78 which is thought to affect CaM binding95, S359 which is specifically 
influenced by cdc2-cyclin B59 and p38δ160, and S366 which is influenced by p70 S6 
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kinase as well as Erk-activated p90RSK1 95. It is not clear what prompts the 
diphosphorylation site in the degron motif (DM), but it is hypothesized to be, in part, 
through autophosphorylation151. Studies have also made progress into detailing the 
mechanisms by which these sites exert control over eEF-2K activity, especially in regards 
to T348 and S500. CaM/Ca2+ has been shown to increase the ability of eEF-2K to 
autophosphorylate T348, which can then bind to a basic allosteric binding pocket that is 
likely to cause a conformational change in the R-loop that allows for enhanced efficiency 
to phosphorylate substrate54,135. Additionally, phosphorylation of S500 has been 
implicated in imparting Ca2+ independent activity of eEF-2K53 and because S500 can also 
be phosphorylated by PKA, under cellular conditions of elevated cAMP it could help 
maintain significant translational pause without calcium signaling138. In summary, there 
are many complex layers of eEF-2K regulation, some yet to be unraveled, to be 
considered when studying mechanism.  
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Scheme 1.2. The activation and activity of eEF-2K.  
(Scheme adapted from Chapters 2 and 4).  The model consists of inactive eEF-2K (E) 
reversibly binding calmodulin (CaM) (k1/k-1) to form an ECaM complex capable of 
phosphorylating eEF-2K on Thr-348 (EP) (k2auto). This is the form of eEF-2K that is a 
prerequisite to phosphorylating substrate (S), but in order to do so Ep must reversibly 
bind CaM, S and ATP (k3/k-3) to form the EpCaMS complex capable of 
phosphorylating S (k4phos).  
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Chapter 2: Effect of pH on eEF-2K Activation 
   
2.1. ABSTRACT 
Eukaryotic elongation factor 2 kinase (eEF-2K) regulates the global rate of 
protein synthesis by phosphorylating and inactivating its only known substrate, 
eukaryotic elongation factor 2 (eEF-2). This is physiologically significant in the context 
of controlling energy expenditure, as translation is a major consumer of cellular energy, 
and whenever it is desirable to control growth, such as during various phases of the cell 
cycle. It follows logically that a protein with such a significant and broad impact as eEF-
2K would also be tightly regulated. Many studies have identified and confirmed that eEF-
2K activity is affected by calcium (Ca2+), calmodulin, autophosphorylations, and 
upstream pathway affecters. This myriad of regulatory inputs converges into a complex 
orchestration of eEF-2K activity that exists on a spectrum of more active to less active, 
rather than a binary switch of on versus off.  
The recent (2011) purification of a robustly active human recombinant kinase has 
allowed for the characterization and biochemical analysis of eEF-2K. Studies have 
investigated and reported effects of autophosphorylations and various in vitro kinetic 
parameters, as well as a detailed kinetic mechanism. While the enzyme has been studied 
under standard in vitro conditions, there have been several reports of eEF-2K being 
affected by pH, which is an effect that remains uncharacterized. The goal of this study 
was to kinetically characterize how acidity modulates the enzyme’s behavior. This is a 
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first step towards understanding an additional way by which eEF-2K adapts to its 
environment.  
 In order to achieve this goal, we looked at the eEF-2K mechanism piecewise. 
Inactive enzyme first binds Ca2+-CaM, which promotes Thr-348 autophosphorylation. 
We refer to this first step as activation. At both this step and after eEF-2K integrates a 
variety of signals into a cohesive output we see as its kinetic activity. Here we report our 
findings of how acidity affects the first activation step of eEF-2K.  
 
2.2. INTRODUCTION 
Protein synthesis represents a large (up to 40%) expenditure of cellular energy. It 
is a process that involves three distinct phases: initiation, elongation and termination, 
each of which have their own regulating factors63,161–163. eEF-2 is one of the primary 
factors controlling elongation, its job being the translocation of the tRNA and growing 
polypeptide chain from the A site to the P site in the ribosome164–166, and its activity is in 
turn controlled by eEF-2K. eEF-2 is the only known substrate of eEF-2K, that is to say 
eEF-2K activity is directly tied to the state of eEF-2 and therefore the progression of 
global protein translation. While eEF-2 has a binary mode of operation 
(unphosphorylated/able to bind the ribosome vs. phosphorylated on Thr-56/unable to 
bind the ribosome) the level of eEF-2K activity appears exists on a continuous 
spectrum34,64,65,154,167,168. 
In order for this to make sense, we must consider individual eEF-2K molecules, 
as well as the cumulative profile of all eEF-2K molecules in the cell. The activity of eEF-
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2K is dependent on external factors, and here “activity” refers to the ability of eEF-2K to 
phosphorylate its substrate, as reflected by the average rate of phosphate incorporation. 
Ca2+/CaM binding, autophosphorylation and multisite phosphorylation via upstream 
pathways are all external factors that must come together into a cohesive output of eEF-
2K activity. If we consider an individual unphosphorylated eEF-2K molecule, it must 
bind Ca2+/CaM, which stabilizes the conformation necessary for autophosphorylation of 
Thr-348, located on a regulatory loop (R-loop) and subsequent binding to a pocket in the 
kinase domain22,35,54,65. We refer to this step as activation (Figure 2.2). Ca2+/CaM has also 
been shown to: 1) enhance peptide substrate phosphorylation via activated eEF-2K 
(already Thr-348 autophosphorylated) and 2) promote autophosphorylation of Ser-500 on 
the activated enzyme. Ser-500, once phosphorylated, promotes calcium-independent 
activity of eEF-2K. In summary, Ca2+/CaM promotes activation of eEF-2K, is necessary 
for efficient substrate phosphorylation, and ultimately allows for continued activity of 
eEF-2K in the absence of Ca2+20,35,36,54,137,138.  
At this point, we are considering an enzyme molecule that is activated via Thr-
348 autophosphorylation, dependent on Ca2+-CaM concentrations for substrate 
phosphorylation, but with activity still potentially independent of Ca2+ fluctuations due to 
Ser-500 phosphorylation. The complexity deepens when we take additional upstream 
effecters into account. The mTOR and MAPK (MEK/ERK) pathways, cAMP-dependent 
protein kinase (PKA) and AMP-activated protein kinase (AMPK) have all been 
implicated in activity-altering phosphorylations of eEF-2K– the former three activating 
and the latter two inhibiting35,95,138,169. As there are so many combinations of regulatory 
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phosphorylations that a single enzyme molecule can have, each one can and must have a 
cohesive output which we can see as the observed average efficiency of substrate 
phosphorylation.  
Finally, an additional form of eEF-2K regulation that has been proposed is pH. 
Common situations accompanied by intracellular pH fluctuations include gamete 
activation and fertilization, cell cycle, and stimulation by mitogens and growth 
factors155,156; cytoplasm acidification has been correlated to global protein synthesis 
suppression and occurs under stress conditions such as ischemia, hypoxia, high intensity 
exercise, diabetic ketoacidosis, and solid tumors7–9,81,157. Precise pH homeostasis is vital 
to cellular function as many processes have evolved to operate at the narrow 
physiological range (typically 7.2-7.5158). Several studies have demonstrated that acidic 
conditions are activating to the enzyme however there has been no in depth kinetic study 
to explain this effect11,154,159. There are several potential mechanisms to mediate acidity-
induced increase in eEF-2K activity, namely either making more active enzyme (i.e. the 
eEF-2K activation steps of CaM binding and T348 autophosphorylation) or making the 
enzyme more active (i.e. increasing intrinsic activity, summarized by an enzyme’s 
catalytic efficiency). This study is the first to use a robustly active recombinant human 
eEF-2K to investigate how lowering pH affects the activating autophosphorylation of 
Thr-348. Detailing the mechanism behind the effect of low pH on eEF-2K could lead to a 
deeper understanding of the mediation of the cellular stress response. 
 
2.3. MATERIALS AND METHODS 
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2.3.1. Reagents, Strains, Plasmids and Equipment 
Yeast extract, tryptone and agar were purchased from USB Corporation 
(Cleveland, OH).  Isopropyl β-D-1-thiogalactopyranoside (IPTG) and dithiothreitol 
(DTT) were obtained from US Biological (Swampscott, MA).  Qiagen (Valencia, CA) 
supplied Ni-NTA Agarose, QIAprep Spin Miniprep Kit, QIAquick PCR Purification Kit 
and QIAquick Gel Extraction Kit.  Restriction enzymes, PCR reagents and T4 DNA 
Ligase were obtained from either New England BioLabs (Ipswich, MA) or Invitrogen 
Corporation (Carlsbad, CA). Lambda Protein Phosphatase was from New England 
BioLabs (Ipswich, MA). BenchMark™ Protein Ladder was from Invitrogen Corporation.  
SIGMAFASTTM Protease inhibitor cocktail tablets for purification of His-tagged proteins, 
ultra-pure grade Tris-HCl, HEPES and calmodulin were from Sigma-Aldrich (St. Louis, 
MO).  All other buffer components or chemicals were purchased from either Sigma-
Aldrich or Fischer Scientific (Pittsburgh, PA).  Amicon Ultrafiltration Stirred Cells, 
Ultracel Amicon Ultrafiltration Discs and Amicon Ultra Centrifugal Filter Units were 
from Millipore (Billerica, MA).  MP Biomedicals (Solon, OH) supplied [γ-32P]ATP.   
Escherichia coli strain DH5α – for cloning – was obtained from Invitrogen 
Corporation, and BL21(DE3) and Rosetta-gami™ 2(DE3) – for recombinant protein 
expression – were from Novagen, EMD4Biosciences (Gibbstown, NJ).  The pET-32α 
vector was obtained from Novagen.   
The ÄKTA FPLC™ System, the HiPrep™ 26/60 Sephacryl™ S-200 HR gel 
filtration column and the HiLoad™ 16/60 Superdex™ 200 prep grade gel filtration column 
were obtained from Amersham Biosciences / GE Healthcare Life Sciences (Piscataway, 
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NJ).  Absorbance readings were performed on a Cary 50 UV-Vis spectrophotometer.  
Radioactivity measurements were performed on either a Packard 1500 Lab TriCarb 
Liquid Scintillation Analyzer or a Wallac MicroBeta® TriLux Scintillation Counter from 
PerkinElmer (Waltham, MA).  Proteins were resolved by Tris-glycine sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), under denaturing conditions on 
10% gels, using the Mini-PROTEAN 3 vertical gel electrophoresis apparatus from Bio-
Rad Laboratories (Hercules, CA).  A Techne Genius Thermal Cycler purchased from 
Techne, Inc. (Burlington, NJ) was used for PCR. 
 
2.3.2. Molecular Biology 
p32TeEF-2K. The modified pET-32α vector (p32TeEF-2K) containing cDNA 
encoding human eEF-2K (GenBank entry NM_013302) was used for the expression of 
Trx-His6-tagged eEF-2K. This expression vector was originally chosen because of the 
thioredoxin tag (Trx-tag) for increased protein solubility and the hexa-histidine tag (His6-
tag) for nickel affinity chromatography purification. There was also an enterokinase 
protease recognition sequence site (DDDDK) that allows for cleavage of the tags, 
however this site had been modified to a Tobacco Etch Virus (TEV) protease recognition 
sequence site (ENLYFQGDI). The vector was modified by the previous graduate student 
Clint Tavares31 using site directed mutagenesis between the KpnI (underlined) and 
EcoRV (italicized) recognition sites (Figure 2.1.A).  Additional plasmid DNA was 
obtained by transforming the modified construct into DH5α cells and purifying the DNA 
using the Qiagen QIAprep Miniprep Kit. The sequence then verified by sequencing at the 
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ICMB Core Facilities, UT Austin, using an Applied Biosystems automated DNA 
sequencer.   
 
2.3.3. Expression and Purification of Proteins 
Expression of eEF-2K. Recombinant human eEF-2K was expressed in the E. coli 
strain Rosetta-gami™ 2(DE3) (Novagen) using the p32TeEF-2K expression vector.  The 
Rosetta-gami™ 2(DE3) cells were chosen because they carry the pRARE2 plasmid which 
supplies tRNAs for seven rare codons. eEF-2K contains 63 rare codons, an 8.7% of its 
725 residues, so the aim with selecting these expression cells was to promote healthy and 
successful expression. 
A single colony of freshly transformed cells was used to inoculate a starter culture 
of LB media containing 135 µM ampicillin, 300 µM chloramphenicol and 20 µM 
tetracycline, and grown overnight at 37 ˚C on a shaker (225 rpm). For co-expressions 
with lambda phosphatase (encoded in a pCDF-Duet (Novagen) expression vector), 70ng 
each of p32TeEF-2K and phosphatase DNA were transformed into the Rosetta-gami™ 
2(DE3) cells and 20µM spectinomycin was added to all LB media. The culture was 
diluted 20-fold into LB media containing the same concentration of antibiotics and 
incubated at 37 ˚C on a shaker (225 rpm) for 3-4 h until it reached an OD600 of 0.6-0.8.  
To induce protein expression the temperature was reduced to 22 ˚C, 0.4 mM isopropyl β-
D-1-thiogalactopyranoside (IPTG) was added and the cultures were incubated for 18h.  
The cells were harvested by centrifugation (7000g for 10 min at 4 ˚C), flash frozen in 
liquid nitrogen and stored at -80 ˚C.   
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Purification of eEF-2K. The purification step of eEF-2K was performed in three 
stages of chromatography (Figure 2.1.B): Ni-NTA, anion exchange and gel filtration. To 
start the bacterial pellet (typically 3.5g wet cells per 1 L of cultured LB) was thawed on 
ice and resuspended in 25mL of Buffer 2.A (20 mM tris-HCl (pH 8.0), 0.5 M NaCl, 5 
mM imidazole, 5 mM MgCl2, 1% triton X-100 (v/v), 0.03% brij 30 (v/v), 0.1% 2-
mercaptoethanol (v/v), 1 mM benzamidine hydrochloride hydrate, 0.1 mM tosyl 
phenylalanyl chloromethyl ketone (TPCK), 0.1 mM phenylmethanesulfonyl fluoride 
(PMSF) and 7 µM lysozyme).  The suspension was sonicated for 12 min (10s pulses) and 
the temperature was monitored and maintained between 4-6 ˚C.  The lysate suspension 
was centrifuged (Sorvall – SS34 rotor) at 27,000g for 30 min at 4 ˚C. The supernatant 
was gently agitated with 600µL of Ni-NTA beads (Qiagen) per liter of culture for 1 h at 4 
˚C.  Prior to agitation, the beads were equilibrated in a chromatography column with 50 
mL of Buffer 2.A per liter of culture and after agitation the beads were washed with 
100mL of Buffer 2.B (20 mM tris-HCl (pH 8.0), 0.25 M NaCl, 40 mM imidazole, 0.03% 
brij 30 (v/v), 0.1% 2-mercaptoethanol (v/v), 1 mM benzamidine hydrochloride hydrate, 
0.1 mM TPCK and 0.1 mM PMSF) per liter of culture.  The Trx-His6-TEV-eEF-2K was 
eluted in four fractions of 10mL of Buffer 2.C (20 mM tris-HCl (pH 8.0), 0.25 M NaCl, 
250 mM imidazole, 0.03% brij 30 (v/v), 0.1% 2-mercaptoethanol (v/v), 1 mM 
benzamidine hydrochloride hydrate, 0.1 mM TPCK and 0.1 mM PMSF) per liter of 
culture. The purification stages were monitored via SDS-PAGE: uninduced culture, 
induced culture, lysis suspension post sonication, centrifuged pellet, centrifuged 
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supernatant, chromatography column wash flow-through and the various elution 
fractions.   
The eluted fractions containing Trx-His6-tagged eEF-2K from the Ni-NTA 
purification were pooled and dialyzed against Buffer 2.D (20 mM tris-HCl (pH 8.0), 0.15 
M NaCl, 5 mM MgCl2 and 0.1% 2-mercaptoethanol (v/v)) for 16h at 4˚C in the presence 
of 1.5% TEV protease (w/w). The extent of cleavage was confirmed by SDS-PAGE.  
After cleavage, the protein was filtered (0.35µm filter) and applied to a MonoQ 
HR 10/100 (column volume 8mL) anion exchange column pre-equilibrated with filtered  
Buffer 2.E (25 mM HEPES (pH 7.5), 0.15 MNaCl, 5 mMMgCl2, 0.03% brij 30 (v/v), 
and 0.1% 2-mercaptoethanol (v/v)). A salt gradient was applied to the column from 0.15–
1.0 M NaCl in Buffer 2.E over 160 mL at a flow rate of 2 mL/min. The eluted fractions 
were collected and protein concentration was monitored with UV; eEF-2K elutes 
approximately 25% into the applied gradient.  
An additional gel filtration step was performed to separate the eEF-2K monomers 
from the aggregates as advised by previous protocols31. Pooled fractions from the anion 
exchange step were concentrated to under 5mL using an Amicon Ultra-15 Centrifugal 
Filter Unit, MW cutoff of 35 kDa (Millipore) and applied to a HiPrep™ 26/60 Sephacryl™ 
S-200 HR gel filtration column pre-equilibrated with Buffer 2.D. The sample was eluted 
over one column volume (320 mL) at a flow rate of 1mL/min.  
Fractions were collected and analyzed for purity using SDS–PAGE; the 
monomeric kinase eluted around 120mL. Select fractions were pooled and dialyzed 
against Buffer 2.F (25 mM HEPES (pH 7.5), 2 mM DTT, 50 mM KCl, 0.1 mM EGTA, 
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0.1 mM EDTA and 10% glycerol) for storage. The dialyzed protein was concentrated 
using a centrifugal filter unit to 5-10 µM, aliquoted, flash frozen in liquid nitrogen and 
stored at -80°C. The concentration of eEF-2K was calculated using its absorbance at 
280nm and the extinction coefficient (A280) of 97150cm-1M-1. Enzyme purity was 
estimated during the chromatography steps by analyzing Coomassie stained, SDS-PAGE 
resolved samples (Figure 2.1.C). Final enzyme integrity was estimated by determining 
specific activity against a peptide substrate (see general kinetic assays).  
Expression and purification of TEV protease. Tobacco Etch Virus protease was 
expressed from the pRK793 expression vector (gifted by Dr. John Tesmer, Life Sciences 
Institute, University of Michigan, Ann Arbor, MI).  The construct was transformed into 
Rosetta-gami™ 2 (DE3) cells, protein expression was induced with 0.5 mM IPTG at 28 °C 
and the culture was incubated for 4h.  The bacterial culture was centrifuged and the cells 
were harvested and purified according to protocols published earlier170,171.   
Expression and purification of calmodulin. The calmodulin (CaM) clone in the 
pET-23 expression vector was gift by Dr. Neal Waxham (Department of Neurobiology 
and Anatomy, University of Texas Medical School at Houston, Houston, TX). The 
construct was transformed into BL21 (DE3) cells (Novagen). 250 mL of LB media 
containing 150 µM ampicillin was inoculated with a single colony and grown overnight 
at 37°C on a shaker (225 rpm). The culture was diluted 20-fold into LB media with 
150µM ampicillin and incubated at 37°C on a shaker (225 rpm) for about 3h until it 
reached an OD600 of 0.6. Protein expression was then induced with 0.5 mM IPTG for 6 
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h at 30°C. The cells were harvested by centrifugation (7000 g for 10 min at 4°C), flash 
frozen in liquid nitrogen and stored at -80°C.   
The bacterial pellet was thawed on ice and resuspended in 25mL of Buffer C1 (50 
mM Tris–HCl (pH 7.5), 10 mM EDTA, 0.1 TPCK, 0.1 mM PMSF and 1 mM 
benzamidine). The suspension was sonicated for 15’ min (20s pulses) and the 
temperature was monitored and maintained between 4–6°C. The lysate was cleared by 
centrifugation (Sorvall –SS34 rotor) at 27,000 g for 30 min at 4°C and the supernatant 
brought to 2.5 M ammonium sulfate over 1h at room temperature. The solution was 
cleared by centrifugation (Sorvall –SS34 rotor) at 12,000g for 10 min at 4°C and the 
supernatant was saturated with ammonium sulfate (about 2.5-3 M) over 1 h. The solution 
was cleared once more by centrifugation (Sorvall –SS34 rotor) at 12,000 g for 10 min at 
4°C, the supernatant was discarded and the pellet was resuspended in 50mL Buffer 2.G 
(50 mM Tris–HCl (pH 7.5), 1 mM EDTA, 200 mM ammonium sulfate, 0.1 TPCK, 0.1 
mM PMSF and 1 mM benzamidine).  
 The resuspended pellet was filtered and applied to a HiPrep™ Phenyl (FF) 16/10 
column pre-equilibrated with Buffer C2. 2.5 mM CaCl2 and 200 mM ammonium sulfate 
were slowly added to the flow through while 50 mL Buffer 2.G was applied to the 
column and discarded. The flow through with added calcium was filtered and reapplied to 
the column pre-equilibrated with Buffer 2.H (50 mM Tris–HCl (pH 7.5), 2 mM CaCl2, 
and 200 mM ammonium sulfate). The column was washed with an additional 50 mL of 
Buffer C3 and the sample was eluted over 100 mL of Buffer 2.I (50 mM Tris–HCl (pH 
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7.5), 1 M NaCl, and 2.5 mM EGTA). SDS-PAGE was used to identify fractions 
containing CaM, and the corresponding fractions were pooled. 
Pooled fractions were concentrated using an Amicon Ultra-15 Centrifugal Filter 
Unit (Millipore) and applied to a 26/60 sephacryl S-200 prep grade gel filtration column 
pre-equilibrated with 50 mM Tris–HCl (pH 8). The sample was eluted over a column 
volumes (320 mL) at a flow rate of 2 mL/min. Fractions were collected and analyzed for 
purity using SDS–PAGE; select fractions were pooled and dialyzed against Buffer 2.J (25 
mM HEPES (pH 7.5). The dialyzed protein was concentrated using a centrifugal filter 
unit, aliquoted, flash frozen in liquid nitrogen and stored at -20°C. The concentration of 
CaM was calculated using its absorbance at 280 nm and the extinction coefficient (A280) 
of 2980 cm-1M-1. Enzyme purity was estimated after each purification step by analyzing 
Coomassie stained, SDS-PAGE resolved samples. These methods were adapted from 
previous protocols172,173. 
 
2.3.4. Analytical Methods 
  General kinetic assays. eEF-2K was assayed at 30°C in Buffer A (25 mM buffer, 
2 mM DTT, 10 µg/mL BSA, 50 mM KAcO, 10 mM MgCl2, 100 µM EGTA, 150 µM 
pep-S) ±50 µM free calcium (added as CaCl2) in a final reaction volume of 100 µL. 1 
mM EGTA was added for assays performed in the absence of calcium. Changes in free 
calcium concentration over varied pH were accounted for using Stanford University’s 
maxchelator calculator. 2 µM CaM was used in assays considered to be CaM saturated, 
varying concentrations (0-100 µM) of CaM were used for dose response curves. Assays 
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were performed using 2 nM eEF-2K (untreated/not expressed with λ-phosphatase) and 
1mM [γ-32P]ATP (100-1000 cpm/pmol). Either HEPES or Bis-Tris buffers were used for 
assays assessing pH dependence in their appropriate buffer range as calculated by The 
University of Liverpool’s PFG buffer calculator. Samples were prepared on ice and all 
reactions and buffers were individually adjusted to the proper pH (range of pH5.8-7.5). 
90 µL of Buffer A was incubated at 30°C for 2 min, 5 µL of enzyme was mixed in and 
heated for an additional 3min, and the reaction was initiated by the addition of 5 µL ATP. 
Samples were quenched at various time points (1-8min) by spotting 10 µL reaction on 
P81 paper and immediately immersing in 0.1 M phosphoric acid. Samples were thrice 
washed for 15minutes in phosphoric acid and once in acetone. Samples were dried and 
analyzed via the Perkin Elmer Tricarb 2910 TR Liquid Scintillation Analyzer. Each data 
point was performed in duplicate. The pH of the remaining reaction was confirmed to be 
consistent with the assay start.  The amount of labeled peptide associated with each paper 
was determined by measuring the cpm on a liquid scintillation counter.  Kinase activity 
was determined by calculating the rate of phosphorylation of eEF-2 (µM.s-1), and the data 
were fitted to equation 2.1.   
 (Equation 2.1) 
The parameters are defined as follows: v, initial velocity; , apparent maximum 
velocity; [S], concentration of varied substrate; , apparent substrate concentration 
required to achieve half maximal activity. 
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Autophosphorylation Assays: eEF-2K was assayed at 30°C in Buffer 2.L (25 mM 
buffer, 2 mM DTT, 10 µg/mL BSA, 50 mM KCl, 10 mM MgCl2, 100 µM EGTA, 0.3 
µM CaM) ±50 µM free calcium (added as CaCl2, calculated as described in general 
kinetic assays) in a final reaction volume of 60 µL. Either HEPES or Bis-Tris buffers 
were used as previously described and the pH of individual reactions were adjusted 
accordingly (range of pH5.8-7.5). Samples were incubated at 30°C for 2 min, 200 nM 
eEF-2K (unphosphorylated; co-expressed with λ-phosphatase) was mixed in and 
incubated for an additional 3 min before the reaction was initiated with ATP (1mM final). 
7 µL of each reaction were quenched in Buffer 2.M (final quench volume 25 µL, 115 ng 
enzyme, 0.1 M EDTA, 5% SDS loading buffer) at varying time points (0-2 h). SDS 
buffer is 250 mM TrisHCl (pH6.8), 10% SDS, 30% glycerol, 5% β-mercaptoethanol, and 
0.02% bromophenol blue. Samples were then analyzed by Western blotting for the 
incorporation of phosphate at Thr-348 with specific antibodies; 50 ng enzyme was loaded 
into each lane. The pH of the remaining reaction was confirmed to be consistent with the 
assay start.   
Western blot analysis and quantification of blots: Immobilon-FL PVDF 
Membrane (Millipore) was used for transfer. Membranes were processed with 25% 
Odyssey ® Blocking Buffer (LI-COR, Lincoln, NE) in TBS, primaries antibodies in 5% 
BSA or non-fat dry milk in TBST, and secondary antibodies in 25% Odyssey ® Blocking 
Buffer in TBST. Blots were scanned and processed on an Odyssey ® Sa Imaging System 
with Image Studio V.3.1 (LI-COR).  
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Antibodies: The following antibodies were purchased from: a. LI-COR: IRDye ® 680RD 
Goat anti-Mouse IgG (H+L) (#926-68170, 1:15000); IRDye 800CW Goat anti-Rabbit 
IgG (H+L) (#827-08365). b. Epitomics (Burlingame, CA): eEF-2K (C-terminal) (catalog 
no. 1754-1). c. ECM Biosciences (Versailles, KY): eEF2K (Thr-348), phospho-specific 
(catalog no. EP4411). eEF2K (Ser-500), phospho-specific (catalog no. EP4451).   
 
2.4. RESULTS 
Nairn et al10 were the first to demonstrate an increase in eEF-2K activity at low 
pH. This group successfully identified eEF-2 (then unnamed) as a substrate of eEF-2K. 
They used phosphorylation assays with cytosolic extracts at pH 7.4 and 6.2 and noted that 
the increase in eEF-2 phosphorylation, and thereby eEF-2K activity, was independent of 
additional CaM/Ca2+ in the assay at pH 6.2. More than a decade later Dorovkov et al11 
demonstrated that acidity induced an increase in eEF-2 phosphorylation and a decrease in 
protein translation in mice. This group also used purified recombinant GST-eEF-2K in 
radiometric phosphorylation assays with both rabbit eEF-2 and peptide to compare basic 
kinetic parameters of varying pH. This group reported relatively unchanged Km,ATP and 
Km,substrate but an increase in Vmax of eEF-2K under low pH. This study also investigated 
the CaM/Ca2+ independence claimed by Nairn et al10 and found that CaM was necessary 
for eEF-2K activity under all conditions. They did not, however, look at the calcium 
dependence and attributed the previous effects to trace CaM in cytosolic extracts. Finally, 
a recent study by Xie et al12 primarily focused on the accompanying effects of associated 
signaling pathways and translation rate in cancer cells; their kinetic work was poorly 
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defined. In summary, in regards to eEF-2K and its relationship to acidity, previous 
studies have found: 1) There is an increased rate under low pH but substrate Km values do 
not reflect an effect on substrate binding. 2) CaM is necessary for activity at all observed 
pH levels. 3) In vitro effects are seemingly translated into cellular observations and 
various histidine residues, which will be discussed in later chapters, may have underlying 
contribution to this effect by acidic conditions. To date no studies have used a tagless 
purified form of eEF-2K with comparable activity to its in vivo counterpart. This means 
we are lacking clearly defined kinetic parameters and a model for a kinetic mechanism to 
describe eEF-2K’s relationship to pH.  
This study analyzes the entire kinetic mechanism of eEF-2K under acidic 
conditions by first breaking it down to its individual parts. To start with, this section 
looks at activation, the first step of the eEF-2K mechanism. Later sections will look into 
CaM binding and substrate phosphorylation.  
 
2.4.1. Assessment of the pH sensitivity of eEF-2K in the presence of calcium 
The first step taken in the study was to confirm previous studies’ observations of 
increased activity of our tagless recombinant eEF-2K under acidic conditions. The pH 
range used in this study generally stays within 6.2-7.5, which is typically the lowest 
observed physiological acidic value158. On occasion we tested down to pH 5.8 for 
extrapolation purposes.  
We used two forms of eEF-2K in our studies; co-expressed with lambda-
phosphatase and not. Even though bacteria do not express CaM, eEF-2K 
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autophosphorylates at very low rates under standard conditions in its absence. Lambda-
phosphatase removes all existing phosphorylations so that the rate of autophosphorylation 
incorporation may be accurately measured. On the other hand, enzyme that is not co-
expressed with the phosphatase is already activated (Thr-348 phosphorylated, not shown) 
and so the rate of activation does not interfere with intrinsic activity (substrate 
phosphorylation) readings.  
To initially study the activity we used 2 nM eEF-2K (not co-expressed with λ-
phosphatase) and 2 µM CaM incubated in reaction buffer (25 mM buffer, 2 mM DTT, 10 
µg/mL BSA, 50 mM KAcO, 10 mM MgCl2, 100 µM EGTA, 150 µM pep-S) with 10 µM 
free calcium (added as CaCl2) in a final reaction volume of 100 µL. HEPES buffer was 
used for pH 7.5 and Bis-Tris was used for pH 6.2. Reactions were initiated with 1mM [γ-
32P]ATP (100-1000cpm/pmol) and samples were quenched at various time points (1, 2, 3, 
4, 6 and 8 min) by spotting 10 µL reaction on P81 paper and immediately immersing in 
0.1M phosphoric acid. The amount of labeled peptide associated with each paper was 
determined by measuring the counts per minute (CPM) on a liquid scintillation counter.  
The rate of phosphate incorporation on the eEF-2 peptide substrate was determined by 
calculating the slope of CPM over time.  Contrary to previous reports11,159, under 
standard conditions for the general kinetic assay (max concentrations of the variables: 2 
µM CaM, 50 µM free calcium, 150 µM peptide) we initially saw a slight decrease in 
eEF-2K activity at lower pH (Figure 2.1; 28.2 ± 0.4 s-1 at pH 7.5 vs. 12.9 ± 0.2 s-1 at pH 
6.2) which prompted further investigation.  
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2.4.2. Assessment of the pH sensitivity of eEF-2K in the absence of calcium 
To further examine the activity of eEF-2K under low pH, we surveyed a matrix of 
varying CaM and calcium concentrations (Ca2+ concentrations were varied 0, 0.001, 0.01, 
0.1 and 10 µM per assay and analyzed at CaM concentrations of 2000, 500, 50 and 5 nM 
at both pH 6.2 and 7.5). The highlights of this matrix are illustrated in Figure 2.2. The 
most striking pattern we noticed was how in the complete absence of calcium (in the 
presence of 1 mM excess chelating EGTA), the pH 6.2 assays retained activity (9.7 ± 0.2 
s-1) while the pH 7.5 assays did not (1.0 ± 0.03 s-1).  
These data support the notion that a moderate decrease in pH from pH 7.5 to 6.2 
has a dramatic effect on the activity of eEF-2K, primarily in the absence of Ca2+.  In light 
of this observation, we continued the study prioritizing the comparison of the presence 
and absence of calcium.   
 
2.4.3. Activation of eEF-2K at low pH in the presence of calcium 
To begin the analysis of eEF-2K autophosphorylation, we used a phosphate-free 
form of the enzyme by co-expressing it with lambda phosphatase. This way the enzyme 
is homogenously at ground zero for examining activation. Examination of the rate of 
autophosphorylation was accomplished by incubating 200 nM enzyme, 0.3 µM CaM and 
50 µM free Ca2+ at pH 6.2 in reaction buffer 2.L (25 mM Bis-Tris, 2 mM DTT, 10 µg/mL 
BSA, 50 mM KCl, 10 mM MgCl2, 100 µM EGTA). Autophosphorylation reactions were 
initiated with 1 mM ATP and were quenched at the indicated timepoints with 0.1 M 
EDTA and 5% SDS loading buffer. Samples were analyzed with SDS-PAGE (50 ng 
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enzyme per well) and western blotting with a phospho-specific Thr-348 antibody to 
monitor autophosphorylation and total eEF-2K as a control. Potential differences that pH 
might make to assay component concentrations were taken into account, primarily total 
free calcium. To ensure the consistency of pH throughout the assay, minimal volume was 
used to initiate reactions and the pH was checked before and after the assay for each 
individual reaction.  
We first assayed autophosphorylation in the presence of 50µM Ca2+ (Figure 2.2). 
Autophosphorylation at 0, 1, 2, 4, 10, 30 and 60min was analyzed at pH6.2 and 7.5. 
Under standard/saturating conditions (pH 7.5, 50µM free Ca2+, 2µM CaM) 
autophosphorylation occurs on the scale of seconds (2.6±0.3/s)54 so this experiment was 
primarily to compare whether eEF-2K could maintain the rate of autophosphorylation at 
pH6.2 comparable to pH7.5. At the aforementioned timepoints (as well as an additional 
30s timepoint, not shown) autophosphorylation under both pH values was saturated and 
so there was no observable difference with this assay.  
 
2.4.2. Activation of eEF-2K at low pH in the absence of calcium 
 To continue the study of pH and eEF-2K autophosphorylation, we repeated the 
assay as described above in the absence of calcium (excess EGTA; Figure 2.4). We were 
expecting the reactions to be slower so we looked at longer timepoints of 0, 2, 5, 30, 60, 
120 and 240min. There was an initial observed difference at the 2min timepoint: 
autophosphorylation at pH7.5 is visibly slower. To look into the difference more closely, 
additional lower timepoints were tested: 5s and 30s for pH6.2 and slightly longer points 
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of 30s, 1m, and 4m for pH7.5 because of the initial slower observed rate. 
Autophosphorylation was saturated at 5 and 30s under pH6.2 and at pH7.5 the phosphate 
was just beginning to incorporate onto Thr-348. These results show that low pH 
accelerates the activation of eEF-2K in the absence of calcium.  
 
2.5. DISCUSSION 
This is the first study to study the in vitro effects of pH on a robustly active 
recombinant human eEF-2K and to break down the mechanism investigation piecewise. 
The only previous study to report kinetic values attributed the difference in eEF-2K 
behavior at low acidity to Vmax; they reported a Vmax of 4 nmol/min/mg at pH 6.6 and 
0.4nmol/min/mg at pH 7.411. Their reported Km for ATP and substrate were not 
significantly different.  
 
2.5.1. Effect of pH on maximal rate of substrate phosphorylation in the presence of 
calcium 
When considering the study of activity using incorporation of phosphate on a 
peptide substrate, we must consider the enzymatic mechanism as a whole, including the 
binding of all substrates :  𝑬𝑷 + 𝑨𝑻𝑷+ 𝑪𝒂𝑴+ 𝑺+  𝑪𝒂𝟐! ⇋  𝑬𝑪𝒂𝑴𝑨𝑻𝑷𝑺     𝒌𝒄𝒂𝒕     𝑬𝑪𝒂𝑴+ 𝑷𝑨𝑫𝑷       (Equation 2.2) 
 Where EP is autophosphorylated/activated enzyme, S is the substrate to be 
phosphorylated, P is phosphorylated substrate, and 𝑘!"! = !!"#[!] .  
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Our kinetic assay measures the maximal rate of substrate phosphorylation within 
the E•CaM•S•ATP complex; under the conditions we use all substrates are expected to 
bind and form the enzyme complex so that we can measure kcat.  Our initial observations 
suggested that low pH does not increase this maximal rate of eEF-2K in the presence of 
saturating calcium and CaM.  In fact, it appears to decrease it slightly in our assay.  The 
observed rate constant under saturating CaM in the presence of calcium were 28.2±0.4 s-1 
at pH 7.5 vs. 12.9±0.2 s-1 at pH 6.2. The differences in kinetic parameters between this 
and previous studies may be attributed to our enzyme preparation which is some 2000 
times more active than the previous standard of GST-tagged eEF-2K. 
 
2.5.2. Effect of pH on observed rate of substrate phosphorylation in the absence of 
calcium 
The highlight from further exploration of Ca2+ and CaM concentrations under low 
pH was the retention of activity at pH 6.2 in the absence of calcium. The observed rate at 
pH6.2 (under saturating conditions including 2 µM CaM and 150 µM pep-S) is 
significantly higher than at pH 7.5 (1.0 ± 0.03 s-1 at pH 7.5 vs. 9.7 ± 0.2 s-1 at pH 6.2).  
This represents the first evidence of a pH-dependent calcium independent mechanism for 
eEF-2K.  
Considering Eqn. 2.2, while we don’t know with certainty that substrates bind to 
form the enzyme complex in the absence of calcium.  Although there is no activity under 
pH 7.5, this is most likely because CaM has not bound rather than ATP or pep-S.  
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2.5.3. Effect of pH on eEF-2K autoactivation in the presence of calcium 
This study reports for the first time the investigation into the impact of pH on 
eEF-2K activation. We used unphosphorylated eEF-2K, time-quench assays, and Western 
blotting to look at relative rates of Thr-348 phosphorylation.  
In our first experiment we were looking to verify that there was no observable 
slowing of autophosphorylation at pH 6.2 in the presence of calcium.  Under standard, 
saturating conditions (max CaM, Ca2+ at pH 7.5) we have previously reported an 
autophosphorylation rate of 2.8 s-1 54. Here, as expected we established that 
autophosphorylation is also fast at pH 6.2 with no observable difference compared to pH 
7.5. 
 
2.5.4. Effect of pH on autoactivation in the absence of calcium 
We observed a difference of eEF-2K behavior under pH 6.2; in the absence of 
calcium, activity was maintained, whereas at pH 7.5 calcium is required to see activity.  
Under the first time course we did see slower autophosphorylation at the lowest timepoint 
of 2 min, though by 5 min both pH were showing saturating autophosphorylation. This 
prompted an examination into smaller timepoints which confirmed that low pH 
accelerates eEF-2K activation in the absence of calcium. We observed max 
autophosphorylation at pH 6.2 at 5 s, and though this is not a precise kinetic measurement 
it is within 2-fold of the 2.8/s rate reported for standard conditions. 
It is important to take the entire autophosphorylation steps together:  𝐸 + 𝐶𝑎𝑀 + 𝐴𝑇𝑃 !!  𝐸𝐶𝑎𝑀𝐴𝑇𝑃 !!  𝐸!𝐶𝑎𝑀                        (Equation 2.3) 
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 Where E is eEF-2K, the first binding/complex formation is defined by the 
equilibrium between binding and dissociation (k1/k-1 = 𝐾!!"#), the second step is a rate 
defined by k2 and represents the autophosphorylation step where EP is phospho-Thr-348-
eEF-2K. Our autophosphorylation experiment does not measure the complex formation 
and autophosphorylation steps separately, that is we don’t know if an effect we observe is 
due to a change in 𝐾!!"# or k2. 
 
2.6. CONCLUSION 
In this chapter we establish that a) the Vmax of eEF-2K does not appear to increase 
at lower pH in the presence of calcium, b) its activity does increase in the absence of Ca2+ 
when CaM is present and c) its intrinsic activity appears to be similar at pH 6.2 in the 
presence and absence of Ca2+. Continuing on to study autophosphorylation in the 
presence and absence of Ca2+ we: 1) established that in the absence of Ca2+ 
autophosphorylation is fast at pH 6.2 (<5 s), 2) established that in the absence of Ca2+ the 
rate of activation is significantly slower at pH 7.5 compared to pH 6.2; and 3) established 
that in the presence of calcium the rate of activation is high at both pH 6.2 and 7.5.  
Taken together these data suggest that eEF-2K and CaM interact differently, and 
perhaps more efficiently, at low pH. This is of significance because it establishes a new 
mechanism whereby CaM is able to robustly stimulate autophosphorylation in the 
absence of calcium, which is typically necessary. Furthermore, this stimulated 
autophosphorylation, that is normally catalyzed by Ca2+, was catalyzed by just a 20-fold 
increase in H+.   
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These studies set the foundation for a more detailed analysis of the mechanism of 
acid-catalyzed activation of eEF-2K in both the presence and absence of Ca2+ and Mg2+, 
using pre-steady state rapid chemical quench and stopped-flow approaches, to define the 
number and order of steps for both CaM binding and autophosphorylation.  Furthermore, 
they also provide the basis for investigating how post-translational modifications of eEF-
2K may influence activation.  In addition, these studies suggest that structural studies will 
be essential to determine the precise role of Ca2+ and H+ ions in the promotion of CaM-
mediated eEF-2K activation.  
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Scheme 2.1. Schematic representation of eEF-2K expression and purification.  
(A) Illustrates the modified p32TeEF-2K vector, as designed and cloned previously31. 
From left to right, the thioredoxin tag increases protein solubility, the histidine tag allows 
for nickel affinity chromatography purification, the thrombin site is meant for cleavage of 
the previous two tags, the S-tag provides an alternative option for purification (unused 
here), and the TEV site (modified, originally an enterokinase cleavage site) was inserted 
to allow for fuller cleavage of the purification tags and a cleaner final protein product. (B) 
Schematic procession of eEF-2K purification: 1) Cleared bacterial lysate is run through a 
Ni-NTA chromatography column which has a strong affinity for the his-tag. 2) The extra 
eEF-2K  
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length of tags are cleaved during an overnight dialysis with TEV protease. 3) Anion 
exchange chromatography is used to increase protein purity and 4) Gel filtration is used 
to separate aggregates from monomers. (C) The final purity of two fractions of 
recombinant eEF-2K sample after gel filtration analyzed by Coomassie stained SDS-
PAGE against BenchMark™ ladder.  
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Scheme 2.2. Mechanism of Activation of eEF-2K.  
Inactive eEF-2K binds CaM/Ca2+ which stabilizes a conformation that allows T348 
autophosphorylation which in turn confers ability to phosphorylate substrate (eEF-2, on 
T56)54. 
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Figure 2.1. (See following page) 
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Figure 2.1. Low pH does not increase rate of eEF-2K activity. 
(A) Our first step was to confirm reports that low pH promotes an increase in eEF-2K 
activity; we used general kinetic assays to address this. 2 nM eEF-2K (untreated/not 
expressed with λ-phosphatase) and 2 µM CaM was incubated in reaction buffer (25 mM 
buffer, 2 mM DTT, 10 µg/mL BSA, 50 mM KAcO, 10 mM MgCl2, 100 µM EGTA, 150 
µM pep-S) ±10 µM free calcium (added as CaCl2) in a final reaction volume of 100µL. 
HEPES buffer was used for pH 7.5 and Bis-Tris was used for pH 6.2. 1 mM EGTA was 
added for the assays performed in the absence of calcium. Reactions were initiated with 1 
mM [γ-32P]ATP (100-1000cpm/pmol) and samples were quenched at various time points 
(1-8min) by spotting 10 µL reaction on P81 paper and immediately immersing in 0.1M 
phosphoric acid. The amount of labeled peptide associated with each paper was 
determined by measuring the counts per minute (CPM) on a liquid scintillation counter.  
The rate of phosphate incorporation (B) was determined by calculating the slope of CPM 
over time.  The significant observation here is contrary to previous reports11,159 the rate of 
substrate phosphorylation (eEF-2K intrinsic activity) does not increase under low pH. 
This was our first clue to look elsewhere for any effect of pH on eEF-2K.  
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Figure 2.2. Low pH rescues eEF-2K activity in the absence of Ca2+.  
While performing general kinetic assay tests on eEF-2K involving calcium under high 
and low pH we discovered an interesting phenomenon (summarized in the table). We 
noticed that in the absence of calcium, which is typically required, acidic conditions 
rescued eEF-2K activity. That is, under saturating (2 µM) CaM in the absence of Ca2+, 
eEF-2K did not have activity at pH 7.5, but did at pH 6.2. This effect is still CaM 
dependent as there was no observable rate in its absence. Experimental details are as 
follows: 2 nM eEF-2K (untreated/not expressed with λ-phosphatase) was incubated in 
reaction buffer (25mM buffer, 2mM DTT, 10µg/mL BSA, 50mM KAcO, 10mM MgCl2, 
100µM EGTA, 150µM pep-S) ±10µM free calcium (added as CaCl2) in a final reaction 
volume of 100µL. HEPES buffer was used for pH 7.5 and Bis-Tris was used for pH 6.2. 
1mM EGTA was added for the assays performed in the absence of calcium. Reactions 
were initiated with 1mM [γ-32P]ATP (100-1000cpm/pmol) and samples were quenched at 
various time points (1-8min) by spotting 10µL reaction on P81 paper and immediately 
immersing in 0.1M phosphoric acid. The amount of labeled peptide associated with each 
paper was determined by measuring the counts per minute (CPM) on a liquid scintillation 
counter.  The rate of phosphate incorporation (reported in the table) was determined by 
calculating the slope of CPM over time.   
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Figure 2.3. Thr-348 Autophosphorylation at pH 6.2 in the presence of Ca2+.  
Assays were carried out with 200 nM enzyme, 0.3 µM CaM and 50 µM free Ca2+ at pH 
6.2 in reaction buffer 2.L (25 mM Bis-Tris, 2 mM DTT, 10 µg/mL BSA, 50 mM KCl, 10 
mM MgCl2, 100 µM EGTA). Autophosphorylation reactions were initiated with 1 mM 
ATP and were quenched at the indicated timepoints with 0.1 M EDTA and 5% SDS 
loading buffer. Samples were analyzed with SDS-PAGE (50 ng enzyme per well) and 
western blotting with a phospho-specific Thr-348 antibody to monitor 
autophosphorylation and total eEF-2K as a control. Here we can see there is no 
observable difference in either the loading control (total eEF-2K) or the activation of 
eEF-2K (Thr-348 autophosphorylation). As phospho-T348 incorporation typically occurs 
on the second timescale, we were expecting to see this saturation at the lowest (1 min) 
point. We were primarily looking to confirm this phenomenon to see that under acidic 
conditions the autophosphorylation wasn’t observably slower.  
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Figure 2.4. Thr-348 Autophosphorylation at pH 7.5 in the presence of Ca2+.  
Assays were carried out with 200 nM enzyme, 0.3 µM CaM and 50 µM free Ca2+ at pH 
7.5 in reaction buffer 2.L (25 mM HEEPS, 2 mM DTT, 10 µg/mL BSA, 50 mM KCl, 10 
mM MgCl2, 100 µM EGTA). Autophosphorylation reactions were initiated with 1 mM 
ATP and were quenched at the indicated timepoints with 0.1 M EDTA and 5% SDS 
loading buffer. Samples were analyzed with SDS-PAGE (50 ng enzyme per well) and 
western blotting with a phospho-specific Thr-348 antibody to monitor 
autophosphorylation and total eEF-2K as a control. Here we can see there is no 
observable difference in either the loading control (total eEF-2K) or the activation of 
eEF-2K (Thr-348 autophosphorylation). As phospho-T348 incorporation typically occurs 
on the second timescale, we were expecting to see this saturation at the lowest (1 min) 
point. We were primarily looking to confirm this that under this timescale acidic and 
normal conditions are comparable.  
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Figure 2.5. Thr-348 Autophosphorylation at pH 6.2 in the absence of Ca2+.  
Assays were carried out with 0µM free Ca2+ (1 mM EGTA), 200 nM enzyme, and 0.3 
µM CaM at pH 6.2 in reaction buffer 2.L (25 mM Bis-Tris, 2 mM DTT, 10 µg/mL BSA, 
50 mM KCl, 10 mM MgCl2). Autophosphorylation reactions were initiated with 1 mM 
ATP and were quenched at the indicated timepoints with 0.1 M EDTA and 5% SDS 
loading buffer. Samples were analyzed with SDS-PAGE (50 ng enzyme per well) and 
western blotting with a phospho-specific Thr-348 antibody to monitor 
autophosphorylation and total eEF-2K as a control. Here we can see that under the 2 min 
timepoint the autophosphorylation was already saturated. We carried out lower time 
points of 5 s and 30 s in an additional experiment (0 min control not shown) and observed 
that even at 5 s autophosphorylation was saturated at pH 6.2.  
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Figure 2.6. Thr-348 Autophosphorylation at high and low pH in the absence of Ca2+. 
Assays were carried out with 0µM free Ca2+ (1 mM EGTA), 200 nM enzyme, and 0.3 
µM CaM at pH 7.5 in reaction buffer 2.L (25 mM HEPES, 2 mM DTT, 10 µg/mL BSA, 
50 mM KCl, 10 mM MgCl2). Autophosphorylation reactions were initiated with 1 mM 
ATP and were quenched at the indicated timepoints with 0.1 M EDTA and 5% SDS 
loading buffer. Samples were analyzed with SDS-PAGE (50 ng enzyme per well) and 
western blotting with a phospho-specific Thr-348 antibody to monitor 
autophosphorylation and total eEF-2K as a control. Here we can see the incorporation of 
phospho-T348 from 0 – 5 min. We carried out additional lower time points to compare to 
pH 6.2 and were able to see a more dramatic progression of phosphate incorporation from 
30 s – 4 min (right) (0 s control not shown). From this we see that in the absence of Ca2+, 
if we take 2-5 min as fully saturated at pH 7.5, at pH 6.2 with 5 s being fully saturating 
autophosphorylation is at least 60 times faster. 
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Chapter 3: Effect of pH on eEF-2K Activity 
 
3.1. ABSTRACT 
Eukaryotic elongation factor 2 kinase (eEF-2K) is one of several proteins 
responsible for regulating protein translation. Eukaryotic elongation factor 2 (eEF-2) is 
the only known substrate of eEF-2K, which inhibits eEF-2 by phosphorylating it on Thr-
56. Recent studies have elucidated the kinetic mechanism for eEF-2K; in summary, there 
is an initial binary on/on switch followed by a multitude of regulators that culminate into 
a volume control. Primarily, it has been various phosphorylation sites (and the cofactors 
and upstream regulators that responsible for the phosphorylations) whose effects on eEF-
2K have been studied. Far fewer studies have been conducted on the nature of the effect 
of acidity on eEF-2K behavior. We have recently looked into the effect of low pH on 
eEF-2K activation and found that autophosphorylation is most profoundly 
affected/maintained in the absence of calcium. The data pointed to the notion that eEF-
2K has an alternate interaction with CaM, which manifests even with a moderate 20-fold 
increase in H+ ions from pH 7.5 to pH 6.2. The next logical step was to look into how the 
kinetics of substrate phosphorylation are affected. We found that the Vmax values for 
peptide phosphorylation were relatively similar across pH and calcium concentration, 
suggesting that regardless of what ions are present CaM adopts a functionally similar 
conformation when bound to eEF-2K. Furthermore, we found that the difference in 
behavior observed at pH 6.2 and pH 7.5 was explained by the CaM dependency. We also 
found that H+ ions augment the ability of Ca2+ ions to promote CaM binding, suggesting 
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that despite both ions promoting CaM binding, their underlying mechanisms exhibit 
distinct elements.  
 
3.2. INTRODUCTION 
Balancing protein synthesis and protein degradation is an integral part of cellular 
homeostasis. Various proteins are constantly being translated to adapt to the needs and 
environment of their cells. Protein synthesis is a major factor in cellular function and 
must be tightly controlled as this process alone can consume up to 40% of the cell’s 
energy. Three ATP/GTP molecules per amino acid are required to translate mRNA into 
proteins, which is where the high-energy expenditure comes from. Eukaryotes have 
evolved several pathways to keep this process in check, including multiple factors 
required for the initiation, elongation and termination stages of translation63,161–163. One 
such factor is eukaryotic elongation factor 2 (eEF-2) which is responsible for moving the 
growing polypeptide chain from the A site to the P site in the ribosome164–166. 
Phosphorylation of eEF-2K on Thr-56 impedes its ability to bind the ribosome; 
eukaryotic elongation factor 2 kinase (eEF-2K) is responsible for this modification. eEF-
2 is the only known substrate of eEF-2K, which therefore functions to halt global protein 
synthesis10,64,65,167. Surprisingly, eEF-2K has also been known to induce the translation of 
select transcripts which seems contradictory to its function174. This effect was observed in 
Aplysia sensory neurons; neurons are known for their tube-like cell body extensions and 
ability to utilize compartmentalization as a regulatory mechanism. In this context, it 
makes sense that eEF-2K may function in a location-specific manner to initiate specific 
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transcript translation. Still, understanding the ways that eEF-2K is regulated may help 
explain how such an effect is possible. More compellingly still, abnormal eEF-2K 
behavior is implicated in a variety of disease states, including several types of cancer, 
Alzheimer’s and depression, which sets an even higher precedent for understanding this 
complex enzyme87,101,179–181,107,111,122,125,175–178. 
Upon its discovery eEF-2K was aptly named Ca2+/CaM-dependent protein kinase 
3 (CaMK-III) because it was identified as needing Ca2+/CaM to exhibit activity154,182,183. 
Over the years it has been determined that Ca2+/CaM is necessary for 
autophosphorylation of Thr-348 and that subsequent autophosphorylation of Ser-500 
confers calcium-independent activity to eEF-2K36,135. Details behind these 
autophosphorylation sites remained elusive for nearly two decades, however we now 
know that the phosphorylation of Thr-348, located on a regulator loop (R-loop), stabilizes 
its binding to a conserved hydrophobic pocket near the catalytic domain that in turn 
allows eEF-2K to bind its substrate20,21,54. Studies have also shown that CaM, though not 
always calcium, is essential for both activation (Thr-348 autophosphorylation) and 
activity (substrate phosphorylation)36,54,64,182. Furthermore, although the precise 
mechanism is unclear, it has been demonstrated that Ser-500 autophosphorylation (or 
phosphorylation via cAMP activated protein kinase (PKA)) serves to enhance eEF-2K 
substrate phosphorylation and enhances the enzyme’s response to CaM both calcium 
bound and in its apo form21,36,138. 
The multisite-phosphorylation regulation of eEF-2K continues with additional 
sites via upstream pathways; various growth factors, via the mitogen-activated protein 
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kinases (MAPKs) and mammalian target of rapamycin mTORC1 pathways, have an 
inhibiting effect on eEF-2K by phosphorylating Ser-78 and Ser-359/Ser-36652,91,169,184–186. 
AMPK on the other hand has been shown to have an activating effect on eEF-2K by 
relieving inhibition of eEF-2K by mTOR as well as phosphorylating eEF-2K on Ser-
491/Ser-492185. An additional layer of regulation, seemingly independent of upstream 
enzymes and phosphorylation sites is pH, which has been shown to activate the enzyme 
and may have physiological significance for slowing down protein synthesis during states 
of stress such as anoxia and hypoxia8,159. However, to date our studies indicate that most, 
if not all, post-translational modifications impinge upon the dynamics and affinity of 
Ca2+/CaM binding and the rate of Thr-348 autophosphorylation.  
pH is a condition that has the potential to affect Ca2+/CaM binding, as acidity has 
been shown to cause CaM to mimic its calcium bound conformation143. Because CaM is 
a necessary ligand for both activation and activity of eEF-2K, pH therefore has the 
potential to affect either or both. Chapter 2 looked at the effect of pH on the activation 
step of eEF-2K and found that acidity was particularly activating in the absence of 
calcium. To look further into understanding how pH regulates eEF-2K, it would be most 
useful to look into how acidity affects the activity, in this case peptide substrate 
phosphorylation, of this enzyme. There has been a lack of mechanistic explanations in 
regards to this effect. Here we report that, contrary to previous reports, the Vmax of eEF-
2K does not change between high and low pH. Under more acidic conditions, in both the 
absence and presence of calcium, we show that the Km for calmodulin decreases. This 
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suggests that acidity promotes the binding of CaM to eEF-2K to generate an active 
complex and that Ca2+ ions further augments the binding.  
 
3.3. MATERIALS AND METHODS 
3.3.1. Reagents, Strains, Plasmids and Equipment 
Yeast extract, tryptone and agar were purchased from USB Corporation 
(Cleveland, OH).  Isopropyl β-D-1-thiogalactopyranoside (IPTG) and dithiothreitol 
(DTT) were purchased from US Biological (Swampscott, MA).  From Qiagen (Valencia, 
CA)  Ni-NTA Agarose, QIAprep Spin Miniprep Kit, QIAquick PCR Purification Kit and 
QIAquick Gel Extraction Kit were purchased. Lambda Protein Phosphatase was from 
New England BioLabs (Ipswich, MA). BenchMark™ Protein Ladder was from Invitrogen 
Corporation.  SIGMAFASTTM Protease inhibitor cocktail tablets for purification of His-
tagged proteins, ultra-pure grade Tris-HCl, HEPES and calmodulin were from Sigma-
Aldrich (St. Louis, MO).  All other buffer components or chemicals were purchased from 
either Sigma-Aldrich or Fischer Scientific (Pittsburgh, PA).  Amicon Ultrafiltration 
Stirred Cells, Ultracel Amicon Ultrafiltration Discs and Amicon Ultra Centrifugal Filter 
Units were from Millipore (Billerica, MA).  MP Biomedicals (Solon, OH) supplied [γ-
32P]ATP.   
Escherichia coli strain DH5α – for cloning – was obtained from Invitrogen 
Corporation, and BL21(DE3) and Rosetta-gami™ 2(DE3) – for recombinant protein 
expression – were from Novagen, EMD4Biosciences (Gibbstown, NJ).  The pET-32α 
vector was obtained from Novagen.   
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The ÄKTA FPLC™ System, the HiPrep™ 26/60 Sephacryl™ S-200 HR gel 
filtration column and the HiLoad™ 16/60 Superdex™ 200 prep grade gel filtration column 
were from Amersham Biosciences / GE Healthcare Life Sciences (Piscataway, NJ).  
Absorbance readings were performed on a Cary 50 UV-Vis spectrophotometer.  
Radioactivity measurements were performed on either a Packard 1500 Lab TriCarb 
Liquid Scintillation Analyzer or a Wallac MicroBeta® TriLux Scintillation Counter from 
PerkinElmer (Waltham, MA).  Proteins were resolved by Tris-glycine sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), under denaturing conditions on 
10% gels, using the Mini-PROTEAN 3 vertical gel electrophoresis apparatus from Bio-
Rad Laboratories (Hercules, CA).  A Techne Genius Thermal Cycler purchased from 
Techne, Inc. (Burlington, NJ) was used for PCR. eEF-2K peptide substrate (pep-S; 
Acetyl-RKKYKFNEDTERRRFL-Amide (2,227.8 Da)) was custom ordered and 
purchased from AnaSpec Technologies (Fremont, CA). P81 cellulose filters were from 
Whatman / GE Healthcare Life Sciences (Florham Park, NJ). 
 
3.3.2. Molecular Biology 
p32TeEF-2K. The modified pET-32α vector (p32TeEF-2K) containing cDNA 
encoding human eEF-2K (GenBank entry NM_013302) was used for the expression of 
Trx-His6-tagged eEF-2K. This expression vector was originally chosen because of the 
thioredoxin tag (Trx-tag) for increased protein solubility and the hexa-histidine tag (His6-
tag) for nickel affinity chromatography purification. There was also an enterokinase 
protease recognition sequence site (DDDDK) that allows for cleavage of the tags, 
67 
 
however this site had been modified to a Tobacco Etch Virus (TEV) protease recognition 
sequence site (ENLYFQGDI). The vector was modified by the previous graduate student 
Clint Tavares31 using site directed mutagenesis between the KpnI (underlined) and 
EcoRV (italicized) recognition sites (Figure 2.1.A).  Additional plasmid DNA was 
obtained by transforming the modified construct into DH5α cells and purifying the DNA 
using the Qiagen QIAprep Miniprep Kit. The sequence then verified by sequencing at the 
ICMB Core Facilities, UT Austin, using an Applied Biosystems automated DNA 
sequencer.   
 
3.3.3. Expression and Purification of Proteins 
Expression and Purification of eEF-2K. Recombinant human eEF-2K was 
expressed in the E. coli strain Rosetta-gami™ 2 (DE3) (Novagen) using the p32TeEF-2K 
expression vector.  The Rosetta-gami™ 2 (DE3) cells were chosen because they carry the 
pRARE2 plasmid which supplies tRNAs for seven rare codons. eEF-2K contains 63 rare 
codons, an 8.7% of its 725 residues, so the aim with selecting these expression cells was 
to promote healthy and successful expression. Expression and purification were 
performed as described in Chapter 2.3 Materials and Methods of this dissertation.  
Expression and purification of TEV protease. Tobacco Etch Virus protease was 
expressed from the pRK793 expression vector (gifted by Dr. John Tesmer, Life Sciences 
Institute, University of Michigan, Ann Arbor, MI).  The construct was transformed into 
Rosetta-gami™ 2(DE3) cells, protein expression was induced with 0.5 mM IPTG at 28 °C 
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and the culture was incubated for 4h.  The bacterial culture was centrifuged and the cells 
were harvested and purified according to protocols published earlier170,171.   
Expression and purification of calmodulin. The calmodulin (CaM) clone in the 
pET-23 expression vector was gift by Dr. Neal Waxham (Department of Neurobiology 
and Anatomy, University of Texas Medical School at Houston, Houston, TX). The 
construct was transformed into BL21(DE3) cells (Novagen). Expression and purification 
were carried out as described in Chapter 2.3 Materials and Methods of this dissertation. 
These methods were adapted from previous protocols172,173. 
 
3.3.4. Analytical Methods 
  General kinetic assays. eEF-2K was assayed at 30°C in Buffer 3A (25 mM 
buffer, 2 mM DTT, 10 µg/mL BSA, 50 mM KAcO, 10 mM MgCl2, 100 µM EGTA, 150 
µM pep-S) ±50µM free calcium (added as CaCl2) in a final reaction volume of 100µL 
unless otherwise specified. 1 mM EGTA was added for assays performed in the absence 
of calcium. Changes in free calcium concentration over varied pH were accounted for 
using Stanford University’s maxchelator calculator. 2 µM CaM was used in assays 
considered to be CaM saturated, varying concentrations (0-100 µM) of CaM were used 
for dose response curves. Assays were performed using 2 nM eEF-2K (untreated/not 
expressed with λ-phosphatase) and 1 mM [γ-32P]ATP (100-1000 cpm/pmol). Either 
HEPES or Bis-Tris buffers were used for assays assessing pH dependence in their 
appropriate buffer range as calculated by The University of Liverpool’s PFG buffer 
calculator. Samples were prepared on ice and all reactions and buffers were individually 
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adjusted to the proper pH (range of pH5.8-7.5). 90 µL of Buffer A was incubated at 30°C 
for 2 min, 5 µL of enzyme was mixed in and heated for an additional 3min, and the 
reaction was initiated by the addition of 5 µL ATP. Samples were quenched at various 
time points (1-8min) by spotting 10 µL reaction on P81 paper and immediately 
immersing in 0.1 M phosphoric acid. Samples were thrice washed for 15 minutes in 
phosphoric acid and once in acetone. Each data point was performed in duplicate. The pH 
of the remaining reaction was confirmed to be consistent with the assay start.  The 
amount of labeled peptide associated with each paper was determined by measuring the 
counts per minute on a liquid scintillation counter.  Kinase activity was determined by 
calculating the rate of phosphorylation of eEF-2 peptide (µM.s-1).  Data where 𝐾!!"">20nM were fit to eqn. 3.1, and the data where <20nM were fitted to equation 
3.1.   
 (Equation 3.1) 
 
𝑘!"#!"" = 𝑘!"#!"" ( 𝐸 + 𝐶 + 𝐾!!"")− 𝐸 + 𝐶 + 𝐾!!"" − 4[𝐸][𝐶]2[𝐸]  
 
(Equation 3.2) 
The parameters are defined as follows: , apparent rate constant; , apparent 
catalytic constant; [C] is the concentration of varied co-activator CaM; [E] is the 
concentration of eEF-2K;  is the apparent CaM concentration required to achieve 
half maximal activity. 
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Data Fitting: Unless otherwise specified all data and equation fitting was performed 
using GraphPad Prism version 6.00 for Windows, GraphPad Software, La Jolla 
California USA, www.graphpad.com  
 
3.4. RESULTS AND DISCUSSION 
The potential for pH to modify the conformation of CaM similarly to Ca2+ means 
that its interaction with eEF-2K may be affected. CaM is essential for both the activation 
and activity phases of the eEF-2K mechanism, and to isolate which step we are looking at 
dephosphorylated (lambda phosphatase co-expressed) enzyme was used to study 
activation in Chapter 2 and pre-activated enzyme will be used for the activity studies to 
follow. To obtain pre-activated (Thr-348 phosphorylated) enzyme, eEF-2K was purified 
and not co-expressed with lambda phosphatase. Although bacteria do not express CaM, 
we have seen that over extended (hours) periods of time, eEF-2K will autophosphorylate 
on Thr-148 without CaM. Presumably, this is not a viable in vivo method of 
autophosphorylation due to the presence of efficient phosphatases. However, since we 
use several cocktails of phosphatase inhibitors throughout the purification process, when 
not co-expressed with lambda phosphatase eEF-2K can be purified in a stoichiometrically 
phosphorylated state. This was confirmed using phospho-specific antibodies and western 
blotting (data not shown).  
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3.4.1. Characterizing the kinetic parameters of eEF-2K at low pH  
pH Does Not Affect the Rate of eEF-2K Activity in the Presence of Calcium. 
The publication by Dorovkov et al.11 was the only previous study to report quantified 
kinetics for eEF-2K at low pH.  This study concluded that increased acidity increased the 
maximal velocity (Vmax) of eEF-2K tenfold and had no effect on the Km of substrates. 
Others76,159 reported similar findings but without quantified data. Our previous data 
(Chapter 2) on the other hand pointed to the exact opposite, where increased acidity 
appeared to increase the affinity for CaM, but had a minimal effect on Vmax. To more 
fully explore this effect, we performed a full CaM-dependence curve at pH 6.2 and pH 
7.5 using saturating (50µM) free calcium. We used a maximal concentration of 1µM 
CaM with 10 serially diluted concentrations. Data were fit to equation 3.1. (Table 3.1). 
The under the two conditions were within two-fold : pH 6.2 was 20.9 ± 0.9 s-1 and 
pH 7.5 was 34.6 ± 0.9 s-1. On the other hand, the  for pH 7.5 was 3.6 ± 0.6 nM and 
for pH 6.2 the  could not be resolved past >0.5nM. This is because at the lowest 
feasible concentration of CaM used the rate did not reach below half the maximal rate. 
Still, from these parameters we can see that there is at least a 7-fold difference in 
between pH 6.2 and 7.5 where the increased acidity reflects tighter CaM binding. This 
effect can be visualized in Figure 3.1.  
eEF-2K Activity Increases with Decreasing pH in the Absence of Calcium. 
From our previous autophosphorylation data (Chapter 2) we saw that acidity more 
prominently effected eEF-2K activity in the absence of calcium. This was of note because 
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there have been no reports for eEF-2K calcium independent activity unless Ser-500 had 
been phosphorylated. A report143 that H+ may have the same effect as Ca2+ on the 
conformation of CaM led to our hypothesis that the effects of low pH on eEF-2K 
activation are especially significant in the absence of calcium, because of the ability of 
H+ ions to promote an ‘active’ CaM conformation and subsequent interaction with eEF-
2K.   
To determine the apparent catalytic constant and Km for CaM, we performed a 
full CaM dose response curves with a minimum of ten serially diluted CaM 
concentrations. At pH 6.2 we used a max CaM concentration of 1µM which was 
sufficient to saturate and level out the maximum observed rate constant.  As expected at 
pH 7.5 there was no observable activity at 1µM CaM or even 5µM. In attempt to level 
out the observed rate constant, or to see if we could saturate enough calmodulin to see 
any activity, we used additional concentrations of 10, 25, 50 and 100 µM. The  kinetic 
parameters derived from these experiments are summarized in Table 3.1. The at pH 
6.2 was 25.6±3.0 s-1 which is consistent with the of both pH 6.2 and 7.5 in the 
presence of calcium. On the other hand the for pH 7.5 without Ca2+ could not be 
determined, as even with 100 µM the observed rate constant did not level out; the 
information we could determine was >6 s-1. Once again, the most notable difference 
was seen in the  where at pH 6.2 it is 36.0 ± 13.2 nM and at pH 7.5 could not be 
determined at all. The pH 6.2 without Ca2+ value is tenfold of the standard pH 7.5 with 
Ca2+. Taking , the concentration of CaM at half-maximal activity, as a reflection of 
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CaM binding to eEF-2K the data suggests that acidity promotes interaction where there 
would otherwise be none.  
 
3.4.2. Mapping the pH dependence of eEF-2K activity 
Data up to this point has supported the hypothesis that acidity promotes eEF-2K 
and CaM binding. To examine this in more detail we performed eEF-2K kinetic assays at 
150 µM peptide, 1 µM CaM and excess EGTA (1 mM) to quench any free Ca2+ (Figure 
3.3). For comparison we also evaluated the rate at pH 6.2 and pH 7.5 in the presence of 
saturating (50 µM) free Ca2+.  To stay within the buffer range limits, pH 5.8-6.6 were 
assayed in Bis-Tris and pH 6.8-7.5 were assayed in HEPES.  
Here we report that in the absence of calcium the observed rate constant ( ) 
increases with an increasing H+ concentration. This is evidenced by the slope of the plot 
of pH vs. kobs where from pH 7.2 to pH 6.4 (the range where the effect by pH most 
changes) the slope is approximately 2 (Figure 3.3). In fact, a good fit through the data 
(green line) corresponds to a model whereby two protonations, corresponding to sites 
with pKa’s of approximately 6.85 drive the proton-catalyzed reaction.   
 
3.4.3 Bis-Tris does not significantly influence results in the absence of calcium 
 Because we use Bis-Tris for our buffer at low pH when normally eEF-2K assays 
are carried out in HEPES, we wanted to ensure that a change in buffer was not affecting 
our observations (Table 3.2). To test this we used 25 mM (assay concentration), 17 mM 
and 10 mM Bis-Tris with saturating peptide (150 µM pep-S), no Ca2+ and varying CaM 
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at pH 6.2 to observe any trend effects and, if possible, extrapolate the trend to zero buffer. 
The 𝑘!"#!"#  for 10, 17 and 25 mM respectively were: 25.8 ± 1.4, 26.7 ± 2.0 and 25.6 ± 3.0 
s-1. Which are consistent with no change. The 𝐾!"#!"#  values for 10, 17 and 25 mM Bis-
Tris respectively were: 26.0 ± 4.8, 10.4 ± 3.8 and 36.0 ± 13.0 nM. Although the 𝐾!"#!"#  
decreases for 17 mM, it does not appear to be due to concentration as it rises again from 
10 to 25 mM. Since we did not see buffer effect here we also looked briefly at pH 6.8 at 
10 mM and 25 mM Bis-Tris as a low and high buffer concentration to see if there was 
any difference. Overall, we did not observe any consistent trend by varying the 
concentration of Bis-Tris; 10 and 25 mM Bis-Tris values, respectively were: 𝐾!"#!"#  of 1.3 
± 0.4 µM and 1.4 ± 0.6 µM; 𝑘!"#!"#  of 27.3 ± 2.5 s-1 and 31.2 ± 3.1 s-1. 
 
3.6. CONCLUSION 
 Previous data (Chapter 2) revealed a novel mechanism where in the absence of 
Ca2+ ions, H+ ions were able to facilitate Thr-348 autophosphorylation of eEF-2K. 
Previous studies performed under standard conditions (pH 7.5) had reported Ca2+ to be 
necessary for eEF-2K activation, and calcium-independent activity was only observed 
after Ser-500 autophosphorylation, for which Thr-348 autophosphorylation was a 
prerequisite36,53. Our working hypothesis was that H+ ions have the potential to replace 
Ca2+ ions in altering the CaM conformation (as seen in the study by Villarroel et al.143) in 
order to promote binding to eEF-2K.  
Here we report kinetics data that supports this hypothesis, but also provide data 
suggesting that H+ and Ca2+ ions augment each other’s effect. These data are summarized 
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as the following points: 1) CaM-eEF-2K interaction is stronger at a lower pH in the 
presence of calcium as evidenced by 𝐾!"#!"#  whereas 𝑘!"#!"# (intrinsic activity/rate of 
substrate turnover) is not affected by pH. 2) We present a novel mechanism where H+ 
ions can facilitate substrate phosphorylation of eEF-2K in compliment to calcium; H+ 
ions promote CaM association in the presence of Ca2+ and maintain [a lower level of] 
activity and CaM association in its absence. That is, both Ca2+ and H+ seem to increase 
the affinity of CaM to eEF-2K. 3) A qualitative assessment of how proton concentration 
affects 𝑘!"#!"# , the increased activity caused by pH seems to be dependent on two protons. 
 With the activation and activity data gathered and described thus far, we have 
uncovered a compelling mechanism for calcium independent behavior of eEF-2K. This 
adds an additional layer to the many regulations of eEF-2K and may help us to 
understand how this versatile enzyme is able to respond to such a diverse array of cellular 
environments. Though we have demonstrated the positive effect of acidity on eEF-2K-
CaM interaction, the underlying cause remains unclear. Further binding and mutagenesis 
studies will be critical for shedding light on this phenomenon. 
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Figure 3.1 Examining the effect of low pH on eEF-2K activity in the presence of 
calcium.  
2mM eEF-2K (untreated/not expressed with λ-phosphatase) was assayed at 30°C in 
Buffer 3A (25mM buffer, 2mM DTT, 10µg/mL BSA, 50mM KAcO, 10mM MgCl2, 
100µM EGTA, 150µM pep-S) +50µM free calcium (added as CaCl2) in a final reaction 
volume of 100µL; varying concentrations (0-100µM) of CaM were used for dose 
response curves. Assays were initiated with 1mM [γ-32P]ATP (100-1000cpm/pmol).  
HEPES was used for pH 7.5 (A) and Bis-Tris was used for pH 6.2 (B). Samples were 
quenched at various time points (1, 2, 3, 4, 6 and 8 min) by spotting 10µL reaction on 
P81 paper and immediately immersing in 0.1M phosphoric acid. Each data point was 
performed in duplicate. The pH of the remaining reaction was confirmed to be consistent 
with the assay start.  The amount of labeled peptide associated with each paper was 
determined by measuring the counts per minute on a liquid scintillation counter.  The rate 
for each CaM concentration was determined by finding the slope of phosphate 
incorporated over time; kinetic parameters were determined by plotting the rates of 
phosphorylation of eEF-2 peptide (µM.s-1) against CaM concentration and fitting the 
curves to equation 3.1 (modified Michaelis-Menten). Calculated parameters are as 
follows: at pH 6.2  = 0.004±0.01 (undeterminable due to assay limits, <0.5 nM) nM 
and  = 20.9±0.7 s-1 and at pH 7.5  = 3.6±0.6 nM and  = 25.6 ± 0.6 s-1.  
Between the two pH, the max rate ( ) did not significantly differ and the CaM Km (
) were too low to accurately identify however it can be seen by the sharper curve that 
binding is tighter at pH 6.2.  
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Figure 3.2. Examining the effect of low pH on eEF-2K activity in the absence of 
calcium. 
2 nM eEF-2K (untreated/not expressed with λ-phosphatase) was assayed at 30°C in 
Buffer 3A (25 mM buffer, 2 mM DTT, 10 µg/mL BSA, 50 mM KAcO, 10 mM MgCl2, 1 
mM EGTA, 150 µM pep-S) in a final reaction volume of 100µL and initiated with 1mM 
[γ-32P]ATP (100-1000cpm/pmol). HEPES was used for pH 7.5 and Bis-Tris was used for 
pH 6.2. Samples were quenched at various time points (1, 2, 3, 4, 6 and 8 min) by 
spotting 10µL reaction on P81 paper and immediately immersing in 0.1M phosphoric 
acid. The pH of the remaining reaction was confirmed to be consistent with the assay 
start.  The amount of labeled peptide associated with each paper was determined by 
measuring the counts per minute on a liquid scintillation counter.  The rate for each CaM 
concentration was determined by finding the slope of phosphate incorporated over time; 
kinetic parameters were determined by plotting the rates of phosphorylation of eEF-2 
peptide (µM.s-1) against CaM concentration and fitting the curves to equation 3.2 
(modified quadratic equation). Kinetic parameters were calculated to be: at pH 6.2  = 
36.0 ± 13.2 nM and  = 25.6 ± 3.0 s-1 and at pH 7.5  was undeterminable because 
the rate never reached a saturating or maximal limit, even at 100µM CaM (standard 
assays use 2µM for saturating CaM. This data supports the hypothesis that eEF-2K and 
CaM interact differently at low pH, and that H+ may take the place of Ca2+ in terms of 
stabilizing this interaction.  
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Figure 3.3. Mapping the pH dependence of eEF-2K activity. 
To determine the continuance of observed effects across the pH range, general kinetic 
assays were performed: 2 nM eEF-2K (untreated/not expressed with λ-phosphatase) was 
assayed at 30°C in Buffer 3A (25 mM buffer, 2 mM DTT, 10 µg/mL BSA, 50 mM 
KAcO, 10 mM MgCl2, 100 µM EGTA, 150 µM pep-S), 1 µM CaM and either 50 µM 
free calcium (added as CaCl2) or a total of 1 mM EGTA in a final reaction volume of 
100µL and were initiated with 1mM [γ-32P]ATP (100-1000cpm/pmol). Changes in free 
calcium concentration over varied pH were accounted for using Stanford University’s 
maxchelator calculator. HEPES was used for pH conditions above pH 6.8 and Bis-Tris 
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was used for assays pH 6.8 and below. Samples were quenched at various time points (1-
8min) by spotting 10µL reaction on P81 paper and immediately immersing in 0.1M 
phosphoric acid. The pH of the remaining reaction was confirmed to be consistent with 
the assay start.  The amount of labeled peptide associated with each paper was 
determined by measuring the counts per minute on a liquid scintillation counter.  The rate 
for each pH was determined by finding the slope of phosphate incorporated over time. 
The best fit through the data (green line, k1 = 21.8 s-1, Ka = 1.4 x 10-7 M) was obtained by 
fitting the data to kobs = (k1H2)/(H2+KaH+Ka2), where k1 is the observed rate constant for 
the CaM•eEF2K complex at low pH, H is the concentration of protons, and Ka is the pKa 
of each of two protonated residues within the CaM•eEF2K complex.  The alternative fit 
through the data (blue line, k1 = 24.7 s-1, Ka = 3.2 x 10-7 M) corresponded to kobs = 
(k1H)/(H+Ka), where it is assumed that only one protonated species contributes to the 
observed reaction at low pH. 
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Table 3.1 A summary of various kinetic parameters for eEF-2K under a CaM dose 
dependence curve. 
 pH 6.2 pH 7.5 
-Ca2+ + Ca2+ -Ca2+ + Ca2+ 
(s-1) 25.6±3.0 20.9±0.7 >6 25.6±0.6 
(nM) 36.0±13.2 <0.5 n/a 3.6±0.6 
This table depicts the kinetic parameters as defined in Figures 3.1 and 3.2. General 
kinetic assays used 2 nM eEF-2K, 1 mM ATP, 150 µM peptide substrate ± 50 µM free 
Ca2+ with 10 concentrations of varying CaM in reaction buffer (HEPES for pH 7.5 and 
Bis-Tris for pH 6.2). Parameters in the presence of calcium were fit with equation 3.1 and 
parameters in the absence of calcium were fit to equation 3.2. pH 6.2  in the presence 
of calcium could not be determined beyond lower than the lowest feasible concentration 
of CaM used. pH 7.5  in the absence of calcium could not be determined because the 
rate did not reach a saturating/maximal limit.  
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Table 3.2. Bis-Tris concentration does not affect kinetic parameters for eEF-2K 
under a CaM dose dependence curve in the absence of Ca2+. 
 [Bis-Tris]: 10 mM 17 mM 25 mM 
pH 6.2 
𝒌𝒎𝒂𝒙𝒂𝒑𝒑 (s-1) 25.8 ± 1.4 26.7 ± 2.0 25.6±3.0 
𝑲𝑪𝒂𝑴𝒂𝒑𝒑 (nM) 26.0 ± 4.8 10.4 ± 3.4 36.0±13.2 
pH 6.8 
𝒌𝒎𝒂𝒙𝒂𝒑𝒑 (s-1) 27.3 ± 2.5  27.4 ± 5.8 
𝑲𝑪𝒂𝑴𝒂𝒑𝒑 (µM) 1.3 ± 0.4  1.4 ± 0.6 
To determine whether Bis-Tris concentration affects experimental results, general kinetic 
assays were performed using 2 nM eEF-2K, 1 mM ATP, 150 µM peptide substrate, 1 
mM EGTA and no Ca2+ with varying CaM in reaction buffer (concentration of Bis-Tris 
as shown). Assays were initiated with 1mM [γ-32P]ATP (100-1000cpm/pmol). Samples 
were quenched at various time points (1-8min) by spotting 10µL reaction on P81 paper 
and immediately immersing in 0.1M phosphoric acid. The pH of the remaining reaction 
was confirmed to be consistent with the assay start.  The amount of labeled peptide 
associated with each paper was determined by measuring the counts per minute on a 
liquid scintillation counter.  The rate for each pH was determined by finding the slope of 
phosphate incorporated over time. Each rate value was plotted against its CaM 
concentration and data were fit to Eqn 3.1. to calculate values shown in the table. Data 
suggests that Bis-Tris does not affect experimental results.   
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Scheme 3.1. Regulation of eEF-2K activity by multisite phosphorylation.  
Between CaM/Ca2+ control and the various possible phosphorylation states (colored 
circles; green for activating and red for inhibiting) it is clear that there are many layers to 
eEF-2K regulation that allow the complex integration of cellular signals. Current studies 
suggest that CaM binding acts as an on/off binary switch while the phosphorylation sites 
act in combination as a volume dial, determining the level of activity54. Of the 
phosphorylation sites discussed here, T348 and S500 are autophosphorylated upon 
Ca2+/CaM stimulation (light blue outline)135, S398 is phosphorylated by AMPK under 
energy stress90, and S500 can be additionally phosphorylated by cAMP-dependent 
protein kinase (PKA)138; these three sites are activating. On the other hand, mTOR via 
downstream kinases phosphorylates the three inhibitory sites: S78 which is thought to 
affect CaM binding95, S359 which is specifically influenced by cdc2-cyclin B59 and 
p38δ160, and S366 which is influenced by p70 S6 kinase as well as Erk-activated p90RSK1 
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95. It is not clear what prompts the diphosphorylation site in the degron motif (DM), but it 
is hypothesized to be the T348 and S500 autophosphorylations151. Studies have also made 
progress into detailing the mechanisms by which these sites exert control over eEF-2K 
activity, especially in regards to T348 and S500. CaM/Ca2+ has been shown to increase 
the ability of eEF-2K to autophosphorylate T348, which can then bind to a basic 
allosteric binding pocket that is likely to cause a conformational change in the R-loop that 
allows for enhanced efficiency to phosphorylate substrate54,135. Additionally, 
phosphorylation of S500 has been implicated in imparting Ca2+ independent activity of 
eEF-2K53 and because S500 can also be phosphorylated by PKA, under cellular 
conditions of elevated cAMP it could help maintain significant translational pause 
without calcium signaling138. In summary, there are many complex layers of eEF-2K 
regulation, some yet to be unraveled, to be considered when studying mechanism.  
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 Chapter 4: Role of Acidity in the Interaction between Calmodulin and 
Eukaryotic Elongation Factor 2 Kinase  
 
4.1. ABSTRACT 
Eukaryotic elongation factor 2 kinase (eEF-2K) is an enzyme whose activity 
results in global downregulation of protein synthesis, making it a key enzyme in cell 
cycle and energy regulation. The initial activation of eEF-2K requires calmodulin (CaM), 
which typically has two calcium (Ca2+) ions when it binds eEF-2K. The binding of CaM 
to eEF-2K allows for the activating autophosphorylation of Thr-348. eEF-2K has one 
known substrate: eukaryotic elongation factor 2, which is inactivated by eEF-2K and is 
responsible for moving tRNA molecules and growing polypeptide chains through the 
ribosome. The inactivating phosphorylation of eEF-2 on Thr-56 by eEF-2K also requires 
CaM.  While CaM is necessary for both activation and substrate phosphorylation, studies 
have shown that Ca2+ is not; either will occur without calcium albeit very slowly. 
Furthermore, phosphorylation of Ser-500 on eEF-2K has been shown to cause calcium 
independent activation and activity comparable to standard/saturating conditions. Our 
data (chapters 2 & 3) were the first to demonstrate calcium-independent activation and 
substrate phosphorylation outside of a post-translational modification; an effect observed 
under acidic conditions. We also observed a tighter interaction between eEF-2K and CaM 
at low pH in the presence of calcium; all of our data up to this point cumulates to the 
hypothesis that H+ ions can replace Ca2+ ions in altering CaM conformation, resulting in 
tighter binding to eEF-2K. In this chapter we continue to explore the nature of the effect 
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of pH on eEF-2K and provide lifetime fluorescence binding data that supports this 
hypothesis.  
 
4.2. INTRODUCTION 
Eukaryotic elongation factor 2 (eEF-2) is responsible for moving the tRNA and 
growing polypeptide chain from the A site to the P site in the ribosome. eEF-2 is the only 
known substrate of eukaryotic elongation factor 2 kinase (eEF-2K) which phosphorylates 
eEF-2K on Thr-56, impeding its ability to bind the ribosome34,64,167,187. eEF-2K activity 
therefore has a direct correlation to global downregulation of protein synthesis. Upon its 
initial discovery, eEF-2K was known as Ca2+/CaM-dependent protein kinase III (CaMK-
III), as the study reported it requiring both Ca2+ and CaM to be active, though studies 
have since then demonstrated calcium independent activity20,34–36. While there is a 
Ca2+/CaM-dependent kinase (CAMK) family of protein kinases, eEF-2K is actually 
classified as an alpha protein kinase, the only CaM/Ca2+ dependent kinase in this family. 
The alpha protein kinase family is a subset of atypical protein kinases (APK) which 
represent the 10% of protein kinases that lack of sequence homology to the 90% of 
conventional protein kinases16,17,39. Alpha kinases are unique to eukaryotes as they 
appeared relatively recently in evolution. Subfamilies of alpha kinases have very different 
domain structures, but share a catalytic domain homology to the myosin heavy chain 
kinases (MHCK)16,17,42. Many, but not all, of the alpha kinases target substrate residues 
within an alpha-helix conformation which is how the family got its name43,44.  
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A crystal structure for eEF-2K has not successfully been defined, likely due to the 
flexible regulatory loop located in the middle of the protein. A cumulation of many 
studies over the decades has allowed us to compile a working model for the domain 
structure and organization of eEF-2K (Scheme 4.1)30,33,48,54,57,58,188. Starting at the N-
terminus, there is a DXDXDG motif that is a potential Ca2+ binding domain (CRD) 
whose role is currently unknown49, followed by the Ser-78 phosphorylation site and a 
calmodulin (CaM) binding domain (CBD) that is critical for activation and the atypical α-
kinase catalytic kinase domain (KD). C-terminal to the KD is a regulatory loop (R-loop) 
that carries four of the main regulatory phosphorylation sites (Thr-348, Ser-359, Ser-366, 
and Ser-398) and a 440DSGXXS445 degron motif (DM). Autophosphorylation of Thr-348 
and its subsequent binding to a conserved binding pocket in the kinase domain is a 
prerequisite for kinase activity54,57. The degron motif involved in recognition by the 
SCFβTrCP ubiquitin ligase and ensuing degradation of eEF-2K. Activation of eEF-2K and 
subsequent diphosphorylation of the serine residues in the DM provide an efficient and 
precise control for translational depression and rapid resumption54–56. Proceeding the DM 
is the Ser-500 phosphorylation site and finally at the C-terminus there are three helical 
SEL1-type domains (SHR) and a C-terminal tail that interact with the KD and are 
necessary for substrate phosphorylation, but not intrinsic activity. This implicates a role 
in protein-protein interactions, although it has been suggested that the extreme C-terminal 
domain of eEF-2K is not a primary eEF-2 docking site on its own33,58.  
The many phosphorylation sites mentioned above provide a flexible and multi-
input method for the cell to fine-tune eEF-2K activity. The first step for regulating eEF-
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2K, as mentioned above, is the binding of CaM/Ca2+ that allows for autophosphorylation 
of Thr-348 and activation of the enzyme54,135. CaM is also required for substrate 
phosphorylation54, and so studying the nature of the interaction between CaM and eEF-
2K can give us insight into understanding the nature of regulation on eEF-2K by CaM. A 
recent study on the mechanism by which CaM affects eEF-2K employed a number of 
methods, including mass spectrometry, small angle x-ray scattering, NMR and 
computational modeling, to gain insight to eEF-2K conformation and binding to CaM. 
Other CaM regulated kinases operate on a release-of-inhibition mode of activation upon 
CaM binding where this event causes a the rearrangement of a substrate-like-moiety 
away from the substrate recognition site53,139,140.  This is not the case for eEF-2K; the 
study demonstrated that in each step of CaM binding, i.e. during activation and substrate 
phosphorylation, there is a favorable change in conformation, allowing for either 
autophosphorylation or substrate interaction139. That is, eEF-2K is rearranged to result in 
a form with an increased intrinsic activity/ability to phosphorylate, rather than an increase 
in ability to bind a substrate53. 
Structural details of the CaM-eEF-2K binding interaction have been reported, but 
it is first important to understand some details of the CaM structure. CaM is a well-
studied calcium modulated protein and at 148 amino acids, it is one of the smaller 
proteins. CaM is composed of two globular domains connected by a flexible linker, 
where each globular domain has two “hands” which can bind Ca2+ ions; CaM can bind a 
total of four Ca2+ ions189,190. This allows CaM to be versatile in its calcium sensitivity as 
its conformation, along with its affinity for other proteins, changes and adapts with each 
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ion it binds142. Interestingly, even in high calcium concentrations CaM binds eEF-2K 
with only two Ca2+ ions bound in the N-terminus. It is the C-terminus of CaM that binds 
the calmodulin-binding domain (CBD) of eEF-2K - the conserved W85 residue on eEF-
2K inserts deep into a hydrophobic cavity on CaM. Meanwhile the Ca2+-loaded N-
terminus of CaM forms sparse and weak interactions elsewhere on the enzyme126,141,142. 
Furthermore, a study of the effect of acidity on the conformation of CaM demonstrated 
that H+ ions have the capability of promoting a similar conformational change in CaM 
similar to Ca2+ binding142,143. 
While CaM is always required for eEF-2K activation and substrate 
phosphorylation, these events will still occur under standard saturating conditions, though 
it is on the timescale of minutes to hours instead of seconds54.  Phosphorylation of Ser-
500 imparts further Ca2+-independent activity of eEF-2K53 where autophosphorylation 
and substrate phosphorylation rates are comparable to standard saturating conditions. Ser-
500 can also be phosphorylated by PKA, under cellular conditions of elevated cAMP it 
could help maintain significant translational pause without calcium signaling138. Our data 
(chapters 2-3) have shown a novel mechanism for a calcium-independent mechanism of 
eEF-2K via acidic conditions, which would provide an additional layer of physiological 
regulation to help explain the in vivo functions of eEF-2K. Our hypothesis and working 
model suggests that protons supplement Ca2+ in favorably altering CaM concentration to 
bind eEF-2K. Our data examining autophosphorylation and substrate phosphorylation at 
low pH support this model however we have not directly tested CaM binding. Our 
previous experiments that look at phosphorylation did not have the resolution to separate 
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the CaM binding and phosphorylation steps (Figure 4.2). By looking at binding directly 
we will gain direct insight into the interaction of CaM and eEF-2K at low pH. In the 
current study we report that in the absence of calcium, eEF-2K is only able to bind CaM 
at low pH. This supports a model where H+ ions supplement Ca2+ ions in causing a 
conformational change in CaM that is favorable to binding eEF-2K.  
 
4.3. MATERIALS AND METHODS 
4.3.1. Reagents, Strains, Plasmids and Equipment 
Yeast extract, tryptone and agar were purchased from USB Corporation 
(Cleveland, OH).  Isopropyl β-D-1-thiogalactopyranoside (IPTG) and dithiothreitol 
(DTT) were purchased from US Biological (Swampscott, MA).  From Qiagen (Valencia, 
CA)  Ni-NTA Agarose, QIAprep Spin Miniprep Kit, QIAquick PCR Purification Kit and 
QIAquick Gel Extraction Kit were purchased. Lambda Protein Phosphatase was from 
New England BioLabs (Ipswich, MA). BenchMark™ Protein Ladder was from Invitrogen 
Corporation.  SIGMAFASTTM Protease inhibitor cocktail tablets for purification of His-
tagged proteins, ultra-pure grade Tris-HCl, HEPES and calmodulin were from Sigma-
Aldrich (St. Louis, MO).  All other buffer components or chemicals were purchased from 
either Sigma-Aldrich or Fischer Scientific (Pittsburgh, PA).  Amicon Ultrafiltration 
Stirred Cells, Ultracel Amicon Ultrafiltration Discs and Amicon Ultra Centrifugal Filter 
Units were from Millipore (Billerica, MA).  MP Biomedicals (Solon, OH) supplied [γ-
32P]ATP.   
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Escherichia coli strain DH5α – for cloning – was obtained from Invitrogen 
Corporation, and BL21(DE3) and Rosetta-gami™ 2(DE3) – for recombinant protein 
expression – were from Novagen, EMD4Biosciences (Gibbstown, NJ).  The pET-32α 
vector was obtained from Novagen.   
The ÄKTA FPLC™ System, the HiPrep™ 26/60 Sephacryl™ S-200 HR gel 
filtration column and the HiLoad™ 16/60 Superdex™ 200 prep grade gel filtration column 
were from Amersham Biosciences / GE Healthcare Life Sciences (Piscataway, NJ).  
Absorbance readings were performed on a Cary 50 UV-Vis spectrophotometer. Proteins 
were resolved by Tris-glycine sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE), under denaturing conditions on 10% gels, using the Mini-PROTEAN 3 
vertical gel electrophoresis apparatus from Bio-Rad Laboratories (Hercules, CA).  A 
Techne Genius Thermal Cycler purchased from Techne, Inc. (Burlington, NJ) was used 
for PCR.  
 
4.3.2. Molecular Biology 
p32TeEF-2K. The modified pET-32α vector (p32TeEF-2K) containing cDNA 
encoding human eEF-2K (GenBank entry NM_013302) was used for the expression of 
Trx-His6-tagged eEF-2K. This expression vector was originally chosen because of the 
thioredoxin tag (Trx-tag) for increased protein solubility and the hexa-histidine tag (His6-
tag) for nickel affinity chromatography purification. There was also an enterokinase 
protease recognition sequence site (DDDDK) that allows for cleavage of the tags, 
however this site had been modified to a Tobacco Etch Virus (TEV) protease recognition 
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sequence site (ENLYFQGDI). The vector was modified by the previous graduate student 
Clint Tavares31 using site directed mutagenesis between the KpnI (underlined) and 
EcoRV (italicized) recognition sites (Figure 2.1.A).  Additional plasmid DNA was 
obtained by transforming the modified construct into DH5α cells and purifying the DNA 
using the Qiagen QIAprep Miniprep Kit. The sequence then verified by sequencing at the 
ICMB Core Facilities, UT Austin, using an Applied Biosystems automated DNA 
sequencer.   
 
4.3.3. Expression and Purification of Proteins 
Expression and Purification of wild type eEF-2K. Recombinant human eEF-2K 
was expressed in the E. coli strain Rosetta-gami™ 2(DE3) (Novagen) using the p32TeEF-
2K expression vector.  The Rosetta-gami™ 2(DE3) cells were chosen because they carry 
the pRARE2 plasmid which supplies tRNAs for seven rare codons. eEF-2K contains 63 
rare codons, an 8.7% of its 725 residues, so the aim with selecting these expression cells 
was to promote healthy and successful expression. Expression and purification were 
performed as described in Chapter 2.3 Materials and Methods of this dissertation.  
Expression and purification of TEV protease. Tobacco Etch Virus protease was 
expressed from the pRK793 expression vector (gifted by Dr. John Tesmer, Life Sciences 
Institute, University of Michigan, Ann Arbor, MI).  The construct was transformed into 
Rosetta-gami™ 2(DE3) cells, protein expression was induced with 0.5 mM IPTG at 28 °C 
and the culture was incubated for 4h.  The bacterial culture was centrifuged and the cells 
were harvested and purified according to protocols published earlier170,171.   
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Expression and purification of calmodulin. The calmodulin (CaM) clone in the 
pET-23 expression vector was gift by Dr. Neal Waxham (Department of Neurobiology 
and Anatomy, University of Texas Medical School at Houston, Houston, TX). The 
construct was transformed into BL21(DE3) cells (Novagen). Expression and purification 
were carried out as described in Chapter 2.3 Materials and Methods of this dissertation. 
These methods were adapted from previous protocols172,173. 
 
4.3.4. Analytical Methods 
  Analysis of calmodulin binding by fluorescence.  eEF-2K was assayed at 27°C 
in Buffer 4.A (25mM buffer, 2mM DTT, 10µg/mL BSA, 50mM KCl, 100µM EGTA, 
0.1µM CaM(C75)IAE (labeled using a protocol as previously described144) ±50µM free 
calcium (added as CaCl2, calculated as previously described) in a final reaction volume of 
500µL. Buffer 4.A was incubated at 27°C for 5min and CaM(C75)IAE was excited at 345 
nm before an emission spectrum was taken. The emission spectrum was used to optimize 
the wavelength for measuring the fluorescence lifetime.  
For a dose response binding curve: eEF-2K (unphosphorylated; co-expressed with λ-
phosphatase) was titrated in incrementally (ranged from 0.5nM-4µM). Either HEPES or 
Bis-Tris buffers were used as previously described and the pH was confirmed and 
adjusted periodically through the titrations.  
For pH dependence: 1µM eEF-2K was added to Buffer 4.A (with Bis-Tris) at pH6.8 and 
HCl was titrated in to reduce the pH 0.2 units per measurement.  
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In both experiments the lifetime fluorescence spectrum was taken after each titration. The 
emission spectrum was taken periodically to account for fluctuations and the lifetime 
measurements were adjusted accordingly (average range 470-480nm). All fluorescent 
measurements were taken with a lifetime fluorometer (Horiba Scientific, Kyoto, Japan).  
Data Fitting. We used the time-correlated single photon counting (TCSPC) 
lifetime fluorescence technique which is particularly useful for short-term decays, as we 
would expect for binding. This by nature requires the data to be digitally processed as it 
is received by the fluorescence machine, and to complete the analysis we used the PTI 
FelixGX program, developed by Horiba Scientific and integrated into the data collection 
process. To determine the number of lifetimes (distinct steps/enzyme species) in 
CaM/eEF-2K binding, we looked at the population of species (defined by different 
intensities) separated into their corresponding time bins (how long each species spends in 
an excited state before emitting a photon) with saturating CaM and eEF-2K (100nM CaM 
with 1µM eEF-2K at pH 7.5). We observed two distinct species and so to fit our lifetime 
binding data we used two lifetime parameters, a double exponential equation (Eqn 4.1) 𝐼 𝑡 = 𝛼!× 𝑒!!/!!  +  𝛼!× 𝑒!!/!!   (Equation 4.1) 
Where I(t) describes the decay of the fluorophore from the excited state to ground state; α 
describes the fraction of bound species; t describes elapsed time; and τ describes the 
lifetime, typically in seconds.  
The fraction of bound species (α) was plotted against concentration of enzyme and data 
were fit to equation 4.2:  
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α 𝑡 = 𝐹 + 𝑑𝐹 ([𝐶]+ [𝑋]+  𝐾!!"")− 𝐶 + 𝑋 + 𝐾!!"" − 4[𝑋][𝐶]2[𝑋]  
 
 
(Equation 4.2) 
where α(t) describes the fraction of bound species over time; F is a correction factor 
defined by the lowest α value; dF is a correction factor defined by the ratio of α max – α min 
/ [X]max-[X]min; [C] is concentration of CaM; [X] is concentration of variable addition 
(usually eEF-2K or [H+] in the case of varied pH); and 𝐾!!"" is the apparent concentration 
of the variable at half max bound species.  
 
4.4. RESULTS & DISCUSSION  
4.4.1. Acidity Rescues Binding in the Absence of Calcium   
We have previously shown (Chapters 2-3) with unphosphorylated enzyme that H+ 
promotes autophosphorylation in the absence of calcium and with Thr-348-
phosphorphorylated (pre-activated) eEF-2K that H+ promotes substrate phosphorylation 
in the absence of calcium. CaM binding is a pre-requisite for both of these steps. In the 
assays used to study these steps CaM and eEF-2K were incubated before the addition of 
ATP to initiate the phosphorylation reaction. The autophosphorylation assays we 
performed did not have the resolution to differentiate between the effect of pH on CaM 
binding vs. intrinsic enzyme activity (Scheme 4.2). However, the substrate 
phosphorylation assay does suggest that the increased activity at low pH is derived from 
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increased binding of CaM. These experiments were useful to establish an effect by pH 
and led to our hypothesis that H+ ions supplements Ca2+ ions in favorably altering the 
conformation of CaM for eEF-2K binding. Here we use a fluorescent assay to study 
directly the effect of pH on CaM binding to eEF-2K in the absence of calcium.  
First we wanted to address whether H+ ions were capable of promoting CaM 
binding in the absence of calcium, so we used a fluorescence lifetime assay to compare 
binding at high and low pH. Fluorescence lifetime measures the amount of time a 
fluorophore spends in an excited state before emitting a photon and returning to the 
ground state; this technique has an advantage over other fluorescence techniques as it an 
absolute measurement and does not rely on fluorescence intensity191.  In the assays we 
used 100 nM i-CaM in reaction buffer (Buffer 4.A), incubated this at 27°C in a 500µL 
quartz cuvette and unphosphorylated eEF-2K was titrated in from 0-1000nM. We used 
unphosphorylated eEF-2K (co-expressed with lambda phosphatase) so that we could 
ensure we were looking at the first CaM binding step in isolation. All assays were 
performed in the absence of calcium and 10mM EGTA. Emission spectra were taken 
periodically to optimize the wavelength for the lifetime spectra, as addition of eEF-2K 
alters emission wavelengths by nm amounts (range of 475-485nM from 0-1000nM eEF-
2K). The lifetime curves of the varying eEF-2K concentrations were fit to a double 
exponential equation (Eqn. 4.1, see Materials and Methods) for the two observed 
lifetimes, whose relative amplitude change upon eEF-2K binding. This equation starts off 
with four variables (two per lifetime); to increase accuracy of fitting, both Ƭ values 
(representing the time spent in a lifetime) were locked because theoretically Ƭ values 
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should not change and the lifetime spectra is a blend of the two α values. The values of α1 
and α2 (for unbound CaM) were calculated by averaging the fitting of the lifetime 
fluorescence with just CaM and buffer (no enzyme) to a double exponential where Ƭ1 = 
1.5s and Ƭ2 = 15.6s. The values of α1 and α2 for bound CaM was calculated by fitting a 
double exponential equation to the observed lifetime spectra in the presence of 5µM 
enzyme using Ƭ1 = 1.5s and Ƭ2 = 15.6s. To calculate the fraction of binding the value of 
α1 and α2 are compared to those at zero and complete binding.   
In Figure 4.1 we can see at pH 6.2 binding is saturated with the addition of 
900nM eEF-2K whereas at pH 7.5 there is no change in lifetime fluorescence from 0-
1.5µM. For pH 6.2, % bound CaM was plotted against eEF-2K concentration and data 
were fit to a quadratic equation (Eqn. 4.2, see Materials and Methods) to examine the 
eEF-2K dependence of i-CaM binding. Here we can see that for pH 6.2, eEF-2K is half 
bound at 130 ± 22nM.  
 
4.4.3. Ability of Mg2+ to replace Ca2+ in CaM binding  
Calmodulin has four so-called EF-hand structural motifs, which are common 
helix-loop-helix structures found in proteins that need to bind Ca2+. Under resting cellular 
conditions magnesium (Mg2+), a chemically similar divalent ion to Ca2+, can exist in 
1000x excess to Ca2+. In order to be a competent calcium signaling protein, CaM must be 
able to distinguish between Mg2+ and Ca2+192,193. While it has been shown that Mg2+ is 
likely too small to engage and bind EF-hands similarly to calcium, there have also been 
reports of Mg2+ associating with both the two N-terminal (I & II) and the two C-terminal 
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(III & IV) EF-hands of CaM. Some reports show Mg2+ being unable to bind EF-hands 
(EF-hand III), some show that Mg2+ binds and induces a local conformational change 
(EF-hand IV), and others show that Mg2+ binds (EF-hands I & II) in a way that stabilizes 
the apo-form of CaM192,194,195. The exact mechanism of when and how Mg2+ affects CaM 
is not fully understood, our concern remained that Mg2+ is used as a stabilizing 
component for ATP in our assays. Reports show that Ca2+ has a much higher affinity for 
CaM than Mg2+ but as we are primarily looking at the effect of H+ on eEF-2K in the 
absence of Ca2+, we wanted to verify that our observed effects are independent of Mg2+. 
To do this all assays were performed in the absence of Ca2+ using 100 nM CaM(C75)IAE 
(i-CaM) in reaction buffer (Buffer 4.A) with 1mM Mg2+; the reaction was incubated at 
27°C in a 500µL quartz cuvette. 
For determination of % CaM bound (Figure 4.2.A): unphosphorylated/inactive 
eEF-2K was titrated in from 0-1000nM. Emission spectra were taken periodically to 
optimize the wavelength for the lifetime spectra as addition of eEF-2K alters emission 
wavelengths by nm amounts (range of 475-485nM from 0-1000nM eEF-2K). The 
lifetime curves were fit to a double exponential equation (Eqn. 4.1, see Materials and 
Methods) for the two lifetimes to calculate % bound CaM. Additional controls were 
performed (not shown) where a total of 10mM magnesium was added (no additional 
effect) and where magnesium was added after binding was saturated with eEF-2K (no 
additional effect). Our data shows that magnesium did not enhance eEF-2K and i-CaM 
binding. 
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For determination of eEF-2K dependence of CaM binding (Figure 4.2.B): % 
bound CaM were plotted against eEF-2K concentration and data were fit to a quadratic 
equation (Eqn. 4.2, see Materials and Methods) to examine the eEF-2K dependence of 
CaM binding. The concentration of half bound eEF-2K (𝐾!!"#!!!) was similar for high 
pH (142.5 ± 53.7nM without Mg2+ and 111.3 ± 54.2nM with Mg2+) but had a nearly two-
fold difference under low pH (130.3 ± 21.8nM without Mg2+ and 236.4 ± 16.9 nM with 
Mg2+). This suggests that Mg2+ may compete slightly with H+ to disturb the binding 
equilibrium.  
 
4.4.4. H+ Dependence of CaM Binding in the Absence of Calcium  
Our binding data up to this point has supported the model for H+ to promote Ca2+-
independent CaM binding to eEF-2K. In order to study the nature of the effect of acidity 
on binding, we performed a pH dependence curve. This can provide information on the 
dependence of binding on the concentrations of H+ ions. To do this we used 100 nM 
CaM(C75)IAE (i-CaM) and 1µM eEF-2K in reaction buffer (Buffer 4.A) incubated at 
27°C in a 500µL quartz cuvette. All assays were performed in the absence of calcium and 
pH was titrated downwards using HCl; the pH was verified after each titration.  This 
occurred in two steps to accommodate buffer limits; HEPES was used from pH 7.5-7.0 
and Bis-Tris was used from 6.8-5.8. Emission spectra were taken periodically to optimize 
the wavelength for the lifetime spectra to check whether addition of acid alters emission 
wavelengths by nm amounts (range of 83-485nM from pH 5.8-7.5 was used). We 
performed several controls (not shown) where we started with titrating in eEF-2K before 
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titrating down in pH (no additional effect), where we added in excess eEF-2K after 
titrating down in pH and reaching saturation of H+ (no additional effect). The lifetime 
curves were fit to a double exponential equation (Eqn. 4.1, see Materials and Methods) 
for the two lifetimes to get the % bound CaM. % bound CaM values were then plotted 
against pH. Here we see that binding increases as pH decreases and saturation occurs at 
pH 6.2 and from pH 6.5 to pH 7.5 is roughly a slope of 2 over a ten-fold change in H+ 
concentration, indicating the involvement of 2 protons in this process.  
 
4.5. CONCLUSION 
Due to the high-energy demand of translation, regulation of protein synthesis is a 
central part of maintaining cellular homeostasis. One such method for inhibiting 
translation is the phosphorylation of eEF-2 by eEF-2K, which prevents the movement of 
tRNA molecules through the ribosome76,167. eEF-2K in turn has many regulatory inputs 
that it must integrate into its overall activity; Ca2+, CaM, upstream kinases and pH have a 
combination of activating and inhibiting effects on the enzyme. eEF-2K has been shown 
to be important under various physiological circumstances such as during the cell cycle, 
during cell stress, and during various neuronal processes59,93,115,196,197. It has also been 
implicated in various diseases including several types of cancer, Alzheimer’s and 
depression71,111,123,198,199. eEF-2K has also seemingly paradoxically been reported to 
promote the translation of select transcripts, and the mechanism behind this remains 
undefined174,200. Understanding the nature of the effect these inputs have on eEF-2K is 
crucial for understanding how this enzyme functions.  
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Previous data (chapters 2-3) demonstrated that H+ are capable of replacing Ca2+ in 
promoting the autophosphorylation and substrate phosphorylation; each are steps that 
require CaM binding54. This was reflected in: 1) The faster rate of autophosphorylation at 
low pH in the absence of calcium. 2) The rescued activity (𝑘!"#!""  = 25.6 ± 3.0 s-1) and 
affinity (𝐾!"#!""  = 36.6±13.2nM) at pH 6.2 in the absence of calcium (pH 7.5 kinetic 
parameters could not be determined as rate of substrate phosphorylation failed to reach 
saturation even at 100µM CaM).  
Our above data, combined with the study that reported a similar effect of H+ as 
Ca2+ on CaM conformation142 led us to the hypothesis that H+ supplements Ca2+ in 
promoting CaM binding to eEF-2K. We initially suspected H+ may replace, rather than 
supplement, Ca2+ in this effect however in the presence of Ca2+ low pH caused at least a 
7-fold decrease in 𝐾!"#!"" . Our data up to this point established an effect by low pH and a 
novel mechanism for Ca2+-independent intrinsic activity, however we have not directly 
assessed CaM binding. To look at eEF-2K and CaM binding directly we used lifetime 
fluorescence. We studied unphosphorylated/inactivate enzyme (co-expressed with 
lambda phosphatase) in the absence of calcium. Here we reveal that low pH promotes the 
binding of CaM and eEF-2K in a calcium independent manner, which supports our 
hypothesis that H+ directly impacts the affinity of CaM for eEF-2K. Highlights from our 
data include: 1) We present a novel mechanism where H+ promotes calcium-independent 
binding to eEF-2K. 2) H+ overrides any effect Mg2+ may have on CaM-eEF-2K binding. 
3) The increase in CaM binding appears to mirror the sensitivity of kobs to pH, supporting 
the notion that the binding of two protons drive the binding of CaM to eEF-2K.    
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Figure 4.1. Acidity rescues CaM binding in the absence of calcium. 
All studies were performed in the absence of calcium. (A) To study the binding of CaM 
and eEF-2K, we looked at the lifetime fluorescence spectra of CaM(C75)IAE (i-CaM). 100 
nM i-CaM in reaction buffer (25 mM buffer, 2 mM DTT, 10 µg/mL BSA, 50 mM KCl, 1 
mM EGTA,) was incubated at 27°C in a 500µL quartz cuvette and unphosphorylated 
eEF-2K was titrated in from 0-1000nM. HEPES was used for pH 7.5 and Bis-Tris was 
used for pH 6.2. Emission spectra were taken periodically to optimize the wavelength for 
the lifetime spectra as addition of eEF-2K alters emission wavelengths by nm amounts 
(range of 475-485nM from 0-1000nM eEF-2K). The lifetime curves of the varying eEF-
2K concentrations were fit to a double exponential equation (Eqn. 4.1, see Materials and 
Methods) for the two lifetimes; the first lifetime represents i-CaM without eEF-2K bound 
and the second i-CaM with eEF-2K bound. Here we can see at pH 6.2 binding is 
saturated with the addition of 850nM eEF-2K whereas at pH 7.5 there is not an change in 
lifetime fluorescence (no change in binding) from 0-1.5µM enzyme. This was the first 
step in establishing an effect on CaM binding that was dependent on pH. (B) % CaM 
bound was plotted against respective eEF-2K concentrations and data were fit to a 
quadratic equation (Eqn. 4.2, see Materials and Methods) to examine the eEF-2K 
dependence of i-CaM binding. Due to artifacts of the experiment even saturating 
quantities of eEF-2K did not appear to reach 100% bound CaM, so we defined the 
calculated 𝑉!"#!"" for each condition (75.1% for pH 6.2 –Ca2+) as 100% and replotted these 
calculations against corresponding CaM concentrations.  There was no binding at pH 7.5 
here in the absence of calcium.  
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Figure 4.2. Binding is not promoted by magnesium.  
All studies were performed in the absence of calcium. It has been reported that 
magnesium may have a similar effect on CaM conformation as calcium. Since 
phosphorylation assays and physiological events use magnesium, oftentimes to stabilize 
ATP, we wanted to check whether magnesium could be contributing to any observed 
effects. (A) 100 nM CaM(C75)IAE (i-CaM) in reaction buffer (25 mM buffer, 2 mM DTT, 
10 µg/mL BSA, 50 mM KCl, 1 mM EGTA,) with 1 mM Mg2+ was incubated at 27°C in a 
500µL quartz cuvette and unphosphorylated eEF-2K was titrated in from 0-1000nM. 
HEPES was used for pH 7.5 and Bis-Tris for pH 6.2. Emission spectra were taken 
periodically to optimize the wavelength for the lifetime spectra as addition of eEF-2K 
alters emission wavelengths by nm amounts (range of 475-485nM from 0-1000nM eEF-
2K). The lifetime curves were fit to a double exponential equation (Eqn. 4.1, see 
Materials and Methods) for the two lifetimes. Here we see that magnesium did not 
significantly alter eEF-2K and i-CaM binding at pH 6.2 or pH 7.5. (B) To quantify these 
results, we looked at eEF-2K dependence of CaM binding by plotting % bound CaM 
against eEF-2K concentration and data were fit to a quadratic equation (Eqn. 4.2, see 
Materials and Methods). 
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Figure 4.3. Correlation of pH to CaM binding in the absence of calcium. 
All studies were performed in the absence of calcium. In order to study the nature of the 
effect of acidity on binding, we performed a pH dependence curve. (A) 100 nM 
CaM(C75)IAE (i-CaM) and 1µM eEF-2K in reaction buffer (25 mM buffer, 2 mM DTT, 
10 µg/mL BSA, 50 mM KCl, 1 mM EGTA,) were incubated at 27°C in a 500µL quartz 
cuvette and pH was titrated downwards using HCl; the pH was verified after each 
titration.  This occurred in two steps to accommodate buffer limits; HEPES was used 
from pH 7.5-7.0 and Bis-Tris was used from 6.8-5.8. Emission spectra were taken 
periodically to optimize the wavelength for the lifetime spectra to check whether addition 
of acid alters emission wavelengths by nm amounts (range of 83-485nM from pH 5.8-7.5 
was used). The lifetime curves were fit to a double exponential equation (Eqn. 4.1, see 
Materials and Methods) for the two lifetimes to get the % bound CaM. (B) % bound CaM 
were plotted against pH. Here we see that binding increases as pH decreases and 
saturation occurs at pH 6.2.  The best fit through the data (green line, Ka = 1.4 x 10-7 M) 
was obtained by fitting the data to %bound = 100% x (H2)/(H2+KaH+Ka2), where H is the 
concentration of protons, and Ka is the pKa of each of two protonated residues within the 
CaM•eEF2K complex.  The alternative fit through the data (blue line, Ka = 2.35 x 10-7 M) 
corresponded to %bound = 100% x  (H)/(H+Ka), where it is assumed that only one 
protonated species contributes to the observed reaction at low pH. (C) Shows a table of 
the pH dependence values, an average of duplicate assays.  
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Scheme 4.1. Proposed domains and regulatory regions in eEF-2K.  
Depiction of the structural layout and regulatory sites of eEF-2K based on various 
truncation studies and homology models48,53,54,57,58,172,201,202.  The highlighted domains 
include the proposed DXDXDG Ca2+-binding site (CRD, pink), the CaM-binding region 
(CBD, blue), the kinase catalytic domain and phosphate binding pocket (PBP) (green), 
the regulatory loop (R-loop) and associated phosphorylation sites, the degron motif (DM, 
lavender), and the C-terminal helical domain (SHR, yellow) containing three SEL1-like 
helical repeats required for eEF-2 binding. The residue numbers assigned are estimates 
based on previous experimental studies and the prediction software30,42,48.  Activating 
phosphorylation sites are shown in green (Thr-348, Ser-398, Ser-500) and inhibitory 
phosphorylation sites are shown in red (Ser-78, Ser-359, Ser-366).  
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Scheme 4.2. Model for CaM binding and eEF-2K intrinsic activity.  
A) eEF-2K (E) activation consists of two steps: 1) CaM binding (defined by the 
equilibrium k1/k-1) which induces a conformational change of eEF-2K; and 2) eEF-2K 
autophosphorylation of Thr-348 (defined by the rate k2, phosphorylated enzyme denoted 
as Ep). The autophosphorylation assay (Chapter 1) does not have the resolution to 
distinguish between these two steps. B) Autophosphorylation of Thr-348 induces a 
conformational change with the allosteric interaction between the phospho-Thr-348 
residue and a phosphate-binding pocket on the kinase domain of eEF-2K. CaM is 
required for substrate phosphorylation however it is not a prerequisite for substrate (S) 
binding; the first step is denoted as a single binding equilibrium (ratio of k3/k-3) however 
it likely exists as several binding equilibria between EP, CaM, S and ATP (not shown). 
Once everything is bound, substrate phosphorylation occurs (resulting in formation of P) 
which is here defined by the rate k4. Activity assays measure the entirety of these binding 
and phosphorylation steps and does not have the resolution to distinguish between them.  
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Chapter 5: Characterization of eEF-2K Histidine Mutants at low pH 
 
5.1. ABSTRACT 
Acidification is a physiological phenomenon occurring under conditions such as 
high-intensity exercise, ischemia, septic shock, diabetic ketoacidosis and solid tumors. 
These are all processes that involve severe cell stress and many involve anaerobic 
glycolysis, which puts cells in a state of high-energy demand. This makes it favorable to 
conserve energy and shut down energy consuming processes such as protein synthesis, 
which use up to 40% of cellular energy. One such mechanism to accomplish this is 
activation of eukaryotic elongation factor 2 kinase (eEF-2K), which phosphorylates and 
inactivates its only known substrate, eukaryotic elongation factor 2 (eEF-2). This 
prevents movement of tRNA through the ribosome and effectively shuts down protein 
translation via the elongation step. eEF-2K has also been shown to promote translation of 
specific transcripts, which is seemingly contradictory and a poorly understood 
mechanism.  
eEF-2K has many regulatory inputs including calmodulin (CaM) and calcium 
(Ca2+) concentration and availability, upstream regulators (cAMP-dependent protein 
kinase A (PKA), mammalian target of rapamycin (mTOR), MAPK (MEK/ERK), AMP-
activated protein kinase AMPK), transient receptor potential cation channel, subfamily 
M, member 7 (TRPM7)) and pH. Many of these are communicated through activating or 
inhibiting multi-site phosphorylations and autophosphorylations, with the exception of 
pH for which the mechanism of regulation is not understood. We have previously 
demonstrated (chapters 2-4) a novel mechanism of H+ ion-promoted calcium-independent 
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intrinsic activity and CaM binding of eEF-2K. From this we have developed a hypothesis 
that H+ overrides the need for calcium in promoting CaM conformations favorable for 
eEF-2K binding. Based on a study by Pandey et. al (2014), our model for the mechanism 
behind this is that H+ and Ca2+ affect CaM conformation similarly, promoting CaM 
binding to eEF-2K in the absence of calcium. This was supported by our binding data 
from chapter 4, however an alternative hypothesis suggested by Xie et al. (2015) is that 
low pH directly affects eEF-2K (or CaM) by ionizing histidine residues. Here we use 
kinetic characterization to identify five histidine residues in eEF-2K that may be 
important for its sustained activity under calcium-independent acidic conditions. 
 
5.2. INTRODUCTION 
Since its discovery in the early 1980’s eukaryotic elongation factor 2 kinase (eEF-
2K) has been established as an important regulator of protein synthesis. Its dysregulation 
has been associated with numerous diseases and aberrant cellular conditions including 
breast cancer, pancreatic cancer, glioblastoma, hypoxia, nutrient deprivation, ischemia, 
depression and Alzheimer’s83,103,111,123,177,203–205; this has identified eEF-2K as a potential 
target for therapeutic treatment and prompted the appearance of many studies in 
understanding this enzyme. Under baseline conditions, eEF-2K is physiologically 
important for the cell cycle, learning, memory and synaptic plasticity6,148,197,206 . eEF-2K 
is likely critically beneficial to all of these conditions because of its ability to tightly 
regulate protein translation, which is a large consumer of cellular energy, to 
resources34,166,207.  
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Eukaryotic elongation factor 2 (eEF-2) is the only validated physiological 
substrate of eEF-2K34. As its name suggests, eEF-2 aids in the elongation phase of 
translation, facilitating the movement of the t-RNA molecules and their associated 
peptide chains through the ribosome from the A-site to the P-site164. Phosphorylation on 
Thr-56 via eEF-2K prevents eEF-2 from binding to the ribosome, thereby effectively 
halting global protein synthesis137,154,167. eEF-2K activity has also been correlated to the 
increased translation of select transcripts in neurons174,207. While this is seemingly 
contradictory it is likely possible due to localized regulation or scaffolding across the 
extended neuron cell bodies, though the mechanism for this effect remains undefined. It 
is certainly possible with the multitude of signals imposed in eEF-2K to allow for its tight 
regulation.  
Among these signals include regulation via Ca2+/CaM binding and multi-site 
phosphorylations by upstream kinases and intramolecular autophosphorylation36,54. 
Pathways involved in responding to cell stress often activate eEF-2K (i.e. AMP-activated 
protein kinase (AMPK)55,80,208–210) whereas those involved in growth and proliferation 
often inhibit eEF-2K (mammalian target of rapamycin (mTOR), MAPK (MEK/ERK), 
cdc2-cyclin B complex, transient receptor potential cation channel, subfamily M, member 
7 (TRPM7))79,148,211–214. Interestingly, though CaM is always a prerequisite for intrinsic 
activity, phosphorylation on Ser-500 (either via cAMP-dependent protein kinase (PKA) 
or autophosphorylation) has been shown to impart Ca2+-independent activity21,138,215. We 
have suggested (Chapters 1-4) that low pH (elevated H+ ion concentrations) is a novel 
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mechanism for imparting calcium-independent intrinsic activity and CaM binding to eEF-
2K.  
Acidification of tissues is often associated with conditions of extreme stress, 
including high-intensity exercise, ischemia, septic shock, diabetic ketoacidosis and solid 
tumors, so it is logical that eEF-2K would be beneficial in these circumstances to shut 
down protein synthesis so cells may better focus on regaining homeostasis178,216–219. Our 
data thus far (looking at activation, substrate phosphorylation and CaM binding) has 
supported the model that H+ and Ca2+ impart similar conformational changes in CaM 
making it favorable to bind eEF-2K. An alternative mechanism explaining the effects of 
low pH on eEF-2K was proposed by a recent study by Xie et. al (2015) where ionizable 
histidine residues may boost CaM binding, intrinsic eEF-2K activity or both. Because 
these studies were performed with GST-tagged eEF-2K, which has notoriously minimal 
activity, we wanted to study the potential effects of histidines at low pH on our 
recombinant human eEF-2K using His to Gln mutants.  Here we report five histidine 
mutants: H103Q, H201Q, H227Q, H230Q, and H288Q which have remarkably blunted 
activity at pH 6.2 in the absence of calcium as compared to wild type eEF-2K.  
 
5.3. MATERIALS AND METHODS 
5.3.1. Reagents, Strains, Plasmids and Equipment 
Yeast extract, tryptone and agar were purchased from USB Corporation 
(Cleveland, OH).  Isopropyl β-D-1-thiogalactopyranoside (IPTG) and dithiothreitol 
(DTT) were purchased from US Biological (Swampscott, MA).  From Qiagen (Valencia, 
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CA)  Ni-NTA Agarose, QIAprep Spin Miniprep Kit, QIAquick PCR Purification Kit and 
QIAquick Gel Extraction Kit were purchased. Lambda Protein Phosphatase was from 
New England BioLabs (Ipswich, MA). BenchMark™ Protein Ladder was from Invitrogen 
Corporation.  SIGMAFASTTM Protease inhibitor cocktail tablets for purification of His-
tagged proteins, ultra-pure grade Tris-HCl, HEPES and calmodulin were from Sigma-
Aldrich (St. Louis, MO).  All other buffer components or chemicals were purchased from 
either Sigma-Aldrich or Fischer Scientific (Pittsburgh, PA).  Amicon Ultrafiltration 
Stirred Cells, Ultracel Amicon Ultrafiltration Discs and Amicon Ultra Centrifugal Filter 
Units were from Millipore (Billerica, MA).  MP Biomedicals (Solon, OH) supplied [γ-
32P]ATP.   
Escherichia coli strain DH5α – for cloning – was obtained from Invitrogen 
Corporation, and BL21(DE3) and Rosetta-gami™ 2(DE3) – for recombinant protein 
expression – were from Novagen, EMD4Biosciences (Gibbstown, NJ).  The pET-32α 
vector was obtained from Novagen.   
The ÄKTA FPLC™ System, the HiPrep™ 26/60 Sephacryl™ S-200 HR gel 
filtration column and the HiLoad™ 16/60 Superdex™ 200 prep grade gel filtration column 
were from Amersham Biosciences / GE Healthcare Life Sciences (Piscataway, NJ).  
Absorbance readings were performed on a Cary 50 UV-Vis spectrophotometer. Proteins 
were resolved by Tris-glycine sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE), under denaturing conditions on 10% gels, using the Mini-PROTEAN 3 
vertical gel electrophoresis apparatus from Bio-Rad Laboratories (Hercules, CA).  A 
Techne Genius Thermal Cycler purchased from Techne, Inc. (Burlington, NJ) was used 
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for PCR. P81 cellulose filters were from Whatman / GE Healthcare Life Sciences 
(Florham Park, NJ). eEF-2K peptide substrate (pep-S; Acetyl-RKKYKFNEDTERRRFL-
Amide (2,227.8 Da)) was custom ordered and purchased from AnaSpec Technologies 
(Fremont, CA).  
 
5.3.2. Molecular Biology 
p32TeEF-2K. The modified pET-32α vector (p32TeEF-2K) containing cDNA 
encoding human eEF-2K (GenBank entry NM_013302) was used for the expression of 
Trx-His6-tagged eEF-2K. This expression vector was originally chosen because of the 
thioredoxin tag (Trx-tag) for increased protein solubility and the hexa-histidine tag (His6-
tag) for nickel affinity chromatography purification. There was also an enterokinase 
protease recognition sequence site (DDDDK) that allows for cleavage of the tags, 
however this site had been modified to a Tobacco Etch Virus (TEV) protease recognition 
sequence site (ENLYFQGDI). The vector was modified by the previous graduate student 
Clint Tavares31 using site directed mutagenesis between the KpnI (underlined) and 
EcoRV (italicized) recognition sites (Figure 2.1.A).  Additional plasmid DNA was 
obtained by transforming the modified construct into DH5α cells and purifying the DNA 
using the Qiagen QIAprep Miniprep Kit. The sequence then verified by sequencing at the 
ICMB Core Facilities, UT Austin, using an Applied Biosystems automated DNA 
sequencer.   
G6 eEF-2K. The modified eEF-2K construct with a truncated N-terminus and R-
loop was a generous gift from the Ghose Lab. This construct was generated to be a 
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stripped-down simplified but functional model for full-length wild type eEF-2K and had 
been shown to exhibit tight 1:1 binding with Ca2+/CaM and require Ca2+/CaM for 
activation and activity under standard conditions in an identical manner to wild type eEF-
2K. This was the construct used to generate the histidine mutants and so is the control 
comparison for experiments in this chapter. The G6-eEF-2K construct was modified as 
follows: residues 0-70 (N-terminus) and 359-489 (part of the R-loop) were truncated and 
the R-loop truncation was replaced with a 6-residue glycine linker.  
eEF-2K mutants. Mutant eEF-2K DNA were a generous gift from the Ghose Lab 
(The City College of New York, NY). Mutants were histidine to glutamine mutations 
(HxQ) on the G6 eEF-2K construct and were cloned into pET15b-SUMO plasmids. They 
are ampicillin resistant and carry a histidine tag for Ni-NTA purification. A list of gifted 
mutants are as follows: H80Q, H87Q, H94Q, H103Q, H115Q, H157Q, H201Q, H227Q, 
H230Q, H268Q, H288Q, H495Q, H527Q, H534Q, H554Q, H557Q, H579Q, H580Q and 
H639Q. These histidine sites were all chosen for their proximity to key domains, such as 
the CaM binding domain, substrate binding domain and catalytic domain.  
5.3.3. Expression and Purification of Proteins 
Expression and Purification of wild type eEF-2K. Recombinant human eEF-2K 
was expressed in the E. coli strain Rosetta-gami™ 2(DE3) (Novagen) using the p32TeEF-
2K expression vector.  The Rosetta-gami™ 2(DE3) cells were chosen because they carry 
the pRARE2 plasmid which supplies tRNAs for seven rare codons. eEF-2K contains 63 
rare codons, an 8.7% of its 725 residues, so the aim with selecting these expression cells 
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was to promote healthy and successful expression. Expression and purification were 
performed as described in Chapter 2.3 Materials and Methods of this dissertation.  
Expression and Purification of eEF-2K histidine mutants. eEF-2K mutants were 
co-expressed with lambda phosphatase (encoded in a pCDF-Duet (Novagen) expression 
vector); 70ng each of pet15b-SUMO mutant and phosphatase DNA were transformed 
into the Rosetta-gami™ 2(DE3) cells. A single colony of freshly transformed cells was 
used to inoculate a starter culture of LB media containing 135 µM ampicillin, 300 µM 
chloramphenicol, 20µM spectinomycin and 20 µM tetracycline, and grown overnight at 
37 ˚C on a shaker (225 rpm). The culture was diluted 20-fold into 500mL LB media 
containing the same concentration of antibiotics and incubated at 37 ˚C on a shaker (225 
rpm) for 3-4 h until it reached an OD600 of 0.6-0.8.  To induce protein expression the 
temperature was reduced to 22 ˚C, 0.4 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) was added and the cultures were incubated for 18h.  The cells were harvested by 
centrifugation (7000g for 10 min at 4 ˚C), flash frozen in liquid nitrogen and stored at -80 
˚C.  
All mutants were purified with Ni-NTA chromatography, possible because of the 
His6 tag in the pet15b-SUMO vector. To start purification the bacterial pellet (typically 
1.5 wet cells per 500L of cultured LB) was thawed on ice and resuspended in 25 mL of 
Buffer 4.A (20 mM tris-HCl (pH 8.0), 0.5 M NaCl, 5 mM imidazole, 5 mM MgCl2, 1% 
triton X-100 (v/v), 0.03% brij 30 (v/v), 0.1% 2-mercaptoethanol (v/v), 1 mM benzamidine 
hydrochloride hydrate, 0.1 mM tosyl phenylalanyl chloromethyl ketone (TPCK), 0.1 mM 
phenylmethanesulfonyl fluoride (PMSF) and 7 µM lysozyme).  The suspension was 
120 
 
sonicated for 12min (10s pulses) and the temperature was monitored and maintained 
between 4-6 ˚C.  The lysate suspension was centrifuged (Sorvall – SS34 rotor) at 27,000g 
for 30 min at 4 ˚C. The supernatant was gently agitated with 300 µL of Ni-NTA beads 
(Qiagen) for 1 h at 4 ˚C.  Prior to agitation, the beads were equilibrated in a 
chromatography column with 50 mL of Buffer 4.A and after agitation the beads were 
washed with 50mL of Buffer 4.B (20 mM tris-HCl (pH 8.0), 0.25 M NaCl, 40 mM 
imidazole, 0.03% brij 30 (v/v), 0.1% 2-mercaptoethanol (v/v), 1 mM benzamidine 
hydrochloride hydrate, 0.1 mM TPCK and 0.1 mM PMSF).  Each mutant was eluted in 
three fractions of 3mL of Buffer 4.C (20 mM tris-HCl (pH 8.0), 0.25 M NaCl, 250 mM 
imidazole, 0.03% brij 30 (v/v), 0.1% 2-mercaptoethanol (v/v), 1 mM benzamidine 
hydrochloride hydrate, 0.1 mM TPCK and 0.1 mM PMSF). The purification stages were 
monitored via SDS-PAGE: uninduced culture, induced culture, lysis suspension post 
sonication, centrifuged pellet, centrifuged supernatant, chromatography column wash 
flow-through and the various elution fractions.   
The eluted fractions containing SUMO-His6-tagged eEF-2K mutants from the Ni-
NTA purification were pooled and dialyzed against Buffer 4.D (25 mM HEPES (pH 7.5), 
2 mM DTT, 50 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA and 10% glycerol). The 
dialyzed protein was concentrated using a centrifugal filter unit to 5-10 µM, aliquoted, 
flash frozen in liquid nitrogen and stored at -80°C. The concentration of eEF-2K was 
calculated using its absorbance at 280 nm and the extinction coefficient (A280) of 
97150cm-1M-1. 
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Expression and purification of TEV protease. Tobacco Etch Virus protease was 
expressed from the pRK793 expression vector (gifted by Dr. John Tesmer, Life Sciences 
Institute, University of Michigan, Ann Arbor, MI).  The construct was transformed into 
Rosetta-gami™ 2(DE3) cells, protein expression was induced with 0.5 mM IPTG at 28 °C 
and the culture was incubated for 4h.  The bacterial culture was centrifuged and the cells 
were harvested and purified according to protocols published earlier170,171.   
Expression and purification of calmodulin. The calmodulin (CaM) clone in the 
pET-23 expression vector was gift by Dr. Neal Waxham (Department of Neurobiology 
and Anatomy, University of Texas Medical School at Houston, Houston, TX). The 
construct was transformed into BL21(DE3) cells (Novagen). Expression and purification 
were carried out as described in Chapter 2.3 Materials and Methods of this dissertation. 
These methods were adapted from previous protocols172,173. 
 
5.3.4. General Analytical Methods 
General kinetic assays. eEF-2K mutants were assayed at 30°C in Buffer 5.A (25 
mM buffer, 2 mM DTT, 10 µg/mL BSA, 50 mM KAcO, 10 mM MgCl2, 100 µM EGTA, 
150 µM pep-S) ±50 µM free calcium (added as CaCl2) in a final reaction volume of 100 
µL. 1 mM EGTA was added for assays performed in the absence of calcium. Changes in 
free calcium concentration over varied pH were accounted for using Stanford 
University’s maxchelator calculator. 1 µM CaM was used in assays considered to be 
CaM saturated. Assays were performed using 2 nM eEF-2K and 1 mM [γ-32P]ATP (100-
1000cpm/pmol). Either HEPES or Bis-Tris buffers were used for assays assessing pH 
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dependence in their appropriate buffer range as calculated by The University of 
Liverpool’s PFG buffer calculator. Samples were prepared on ice and all reactions and 
buffers were individually adjusted to the proper pH (range of pH5.8-7.5). 90 µL of Buffer 
5.A was incubated at 30°C for 2 min, 5µL of enzyme was mixed in and heated for an 
additional 3min, and the reaction was initiated by the addition of 5 µL ATP. Samples 
were quenched at various time points (1-8min) by spotting 10 µL reaction on P81 paper 
and immediately immersing in 0.1 M phosphoric acid. Samples were thrice washed for 
15minutes in phosphoric acid and once in acetone. Each data point was performed in 
duplicate. The pH of the remaining reaction was confirmed to be consistent with the 
assay start.  The amount of labeled peptide associated with each paper was determined by 
measuring the counts per minute on a liquid scintillation counter.  Kinase activity was 
determined by calculating the rate of phosphorylation of eEF-2 peptide (µM.s-1).  Data 
where 𝐾!!"">20 nM were fit to eqn. 3.1, and the data where <20 nM were fitted to 
equation 5.1.   
 (Equation 5.1) 
 
𝑘!"#!"" = 𝑘!"#!"" ( 𝐸 + 𝐶 + 𝐾!!"")− 𝐸 + 𝐶 + 𝐾!!"" − 4[𝐸][𝐶]2[𝐸]  
 
(Equation 5.2) 
The parameters are defined as follows: , apparent rate constant; , apparent 
catalytic constant; [C] is the concentration of varied co-activator CaM; [E] is the 
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concentration of eEF-2K;  is the apparent CaM concentration required to achieve 
half maximal activity. 
 CaM Dependence. Calmodulin dose response assays were performed on mutants 
that were selected for further analysis. The same protocol as general kinetic assays were 
performed, except each mutant was assayed under ten varying CaM concentrations: 0, 1, 
5, 10, 25, 500, 100, 250, 500, 1000 nM.  
Data Fitting: Unless otherwise specified all data and equation fitting was 
performed using GraphPad Prism version 6.00 for Windows, GraphPad Software, La 
Jolla California USA, www.graphpad.com 
 
5.4. RESULTS & DISCUSSION 
5.4.1. Initial screening of eEF-2K histidine mutants   
eEF-2K was first discovered and appropriately named  Ca2+-calmodulin mediated kinase 
III (CaMK-III) as calmodulin binding is a prerequisite for eEF-2K activation and substrate 
phosphorylation34,220. Ca2+ under normal conditions is also necessary as it promotes a CaM 
conformation favorable to eEF-2K binding; Ca2+-independent activity has previously only been 
seen following Ser-500 phosphorylation36,135,220.  CaM is bilobal (with each lobe having two 
calcium-binding EF-hands) and is known to bind eEF-2K with its C-terminal domain (without 
calcium) and to loosely associate with its N-terminal domain (calcium bound)33,190,221. In previous 
chapters, we have: 1) Demonstrated a novel mechanism for H+ ion-promoted Ca2+-independent 
intrinsic activity (both autophosphorylation and substrate phosphorylation) of eEF-2K; and 2) 
Proposed that the likely mechanism behind this effect is due to a H+-mediated increased binding 
of CaM to eEF-2K. It has been also been suggested as an alternate mechanism that the ionizable 
app
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imidazole group on histidine residues could have altered pKas that directly affect eEF-2K under 
acidic conditions12.  
The initial study by Xie et al. (2015) that looked into the effect of histidine residues on 
eEF-2K activity identified five conserved histidine residues: three in the CaM binding site (His-
80, His-87 and His-94) and two in the ATP binding site (His-227 and His-230) as being critical to 
the enzyme’s activation by acidity. It is important to note that these studies were performed using 
the GST-tagged form of eEF-2K, which as discussed earlier has minimal activity compared to our 
human recombinant His6-tagged enzyme. We decided to expand this list of residues to those that 
are highly conserved and in the CaM binding domain (CBD) (His-80, His-87, His-94), two in 
between domains (His-103, His-115), in the kinase domain (His-157, His-201, His-227, His-230, 
His-268, His-288), and in the Sel1-like helical repeats (SHR) necessary for substrate interaction 
(His-527, His-534, His-495, His-579, His-580, His-639) (Scheme 5.1). To test which histidine 
mutants could be contributing to eEF-2K activity under low pH, various eEF-2K histidine to 
glutamine mutants were screened. The histidine mutations were generated using the G6 eEF-2K 
construct, which is a fully functional simplified model of full length eEF-2K. It has a truncated N-
terminus and partially truncated R-loop that is replaced with a 6-residue glycine linker. All 
comparisons for the histidine mutants are made against the non-mutated G6 eEF-2K enzyme.  
The rates under the conditions pH 6.2 (using Bis-Tris) in the absence of calcium and pH 7.5 
(using HEPES) in the presence of calcium were measured to look at the ability of the mutant to 
retain activity under low pH and to verify the mutant had activity under standard conditions, 
respectively. 2 nM enzyme, 50 nM CaM, 150 µM substrate peptide and either 10 mM EGTA (pH 
6.2) or 50 µM free calcium (pH 7.5) were incubated in reaction buffer (Buffer 5.A) before 
initiating substrate phosphorylation with 1 mM γ-32P-ATP. Phosphate incorporation was 
measured over time and the corresponding slope for each enzyme is reported above as the 
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observed rate (kobs). G6-eEF-2K and mutant parameters used 50nM CaM to mitigate against the 
saturation of CaM binding masking any minor fluctuations in kinetic behavior due to a mutation 
(originally mutants were tested with 500 nM CaM (not shown) which didn’t fully show the 
difference between the two conditions). Specifically, we were looking for mutants to further 
characterize that had activity at pH 7.5 in the presence of calcium but had significantly lower 
activity under pH 6.2 without calcium (opposite of G6-eEF-2K) enzyme. To determine which 
mutants to further characterize, the ratio between kobs of pH 6.2 in the absence of Ca2+ (where a 
histidine residue could potentially be critical) and pH 7.5 in the presence of Ca2+ (where the 
activity of the enzyme should be optimal) was calculated and compared to the G6-eEF-2K (ratio 
of 1.1  (Table 5.1). We selected mutants with at least a two-fold difference in ratio (ratio < 0.32) 
to study further: H103Q, H201Q, H227Q, H230Q and H288Q. Also of note were four 
consecutive mutants (His-527, His-534, His-495, His-579) in the SHR domain that did not have 
activity at either pH. This may be due to sub-optimized expression and purification conditions, as 
the SDS-PAGE and Coomassie-stained gel showed the presence of eEF-2K in the purification 
(not shown); additional studies are needed to clarify these mutants.  
 
5.4.2. Characterization of CaM dependence of select eEF-2K histidine mutants 
Here we are the first to report a quantitative kinetic analysis, namely parameters 
associated with a CaM dose response curve, of eEF-2K histidine mutants with the goal of 
identifying potential residues contributing to eEF-2K activity under acidic conditions. 
The following histidine mutants with a two-fold difference in pH 6.2 – Ca2+: pH 7.5 + 
Ca2+ ratio from G6-eEF-2K were selected for further characterization: H103Q, H201Q, 
H227Q, H230Q, H288Q. 2nM of each mutant was incubated with various CaM 
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concentrations (0, 1, 5, 10, 25, 50, 250, 500, 1000 nM), 10 mM EGTA and 150 µM 
substrate peptide at 27°C in reaction buffer (Buffer 5.A, Bis-Tris) at pH 6.2 before 
substrate phosphorylation was initiated with 1mM γ-32P-ATP (Figure 5.1). Each CaM dose-
response curve was performed in duplicate and kobs for each mutant was plotted against CaM to 
determine the maximum apparent rate constant (𝑘!"#!"" ) and the concentration of CaM at half max 
rate (𝐾!"#!""). The 𝑘!"#!""  and 𝐾!"#!""  for each mutant, respectively, were: H103Q (4.0 ± 0.2 s-1, 
14.6 ± 3.8 nM), H201Q (1.1 ± 0.03 s-1, 6.3 ± 1.1 nM), H227Q (1.0 ± 0.2 s-1, 47.7 ± 26.3 
nM), H230Q (1.0 ± 0.1 s-1, 26.3 ± 7.9 nM), H288Q (n/a, n/a) compared to G6-eEF-2K 
(41.8 ± 0.8 s-1, 3.9 ± 0.5 nM). H288Q parameters could not be established because there 
was no activity. The other mutants had 𝑘!"#!""  values ranging from 1 - 4 s-1, were 4-5 times less 
active at pH 6.2 –Ca2+ than at pH 7.5 + Ca2+and were all 6.5-25 times less active than G6-eEF-2K 
enzyme under the same conditions (pH 6.2 –Ca2+).  H227Q and H230Q likely affect CaM binding 
as they have a 𝐾!"#!""  7-12 times higher than G6-eEF-2K (47.7 ± 26.3, 26.3 ± 7.9 and 3.9 ± 0.5 nM 
respectively). The remaining 𝐾!"#!""  values are comparable or lower than G6-eEF-2K, so loss of 
activity from mutations are not likely due to an impact on CaM binding. All this taken together 
supports the model that these histidine residues may contribute to promoting Ca2+-independent 
activity under acidic conditions, although this is likely in tandem with the H+ effect on CaM 
binding described in previous chapters.  
 
5.6. CONCLUSION 
eEF-2K has many signaling inputs which primarily involve the interpretation of 
multisite phosphorylation by the enzyme in order to have various levels of global 
downregulation of protein synthesis21,135. pH is a form of regulation on eEF-2K that does 
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not rely on phosphorylation to convey its effect; our previous data (Chapters 1-4) has 
suggested a model in which H+ and Ca2+ affect CaM conformation similarly, promoting 
its binding to eEF-2K and subsequently autophosphorylation and substrate 
phosphorylation. In this model acidity is still affecting eEF-2K indirectly through 
enhanced CaM affinity. To address the question of whether low pH could be directly 
effecting the enzyme through ionizable histidine residues we looked into 17 conserved 
histidine to glutamine mutants. We screened for mutants that retained activity under 
standard conditions (pH 7.5 with calcium) but had significantly lower activity under 
acidic conditions in the absence of calcium. We further studied five mutants and their 
CaM dose dependence curve to further characterize how different their behavior was 
under acidic conditions and compare them to G6-eEF-2K.  
Here we predict that the histidine residues: H103Q, H201Q, H227Q, H230Q, 
H288Q supplement the effect of H+ promotion of Ca2+-independent eEF-2K activation, 
activity, and CaM binding to achieve the overall phenomenon of upregulation of eEF-2K 
under low pH. Further mutation studies could be useful to more concretely identify effect 
on CaM binding (our data suggests histidine mutations have an effect on activity 
independent of binding), to study the effect if histidine was replaced with a positively 
charged amino acid such as lysine, and to determine pKas of the residues to determine 
physiological relevance.  
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Table 5.1. A summary of eEF-2K histidine mutant activities.  
 
Enzyme 
pH 6.2 –Ca2+ 7.5 +Ca2+ 
Vmax Ratio 
Vobs(s-1) Vobs (s-1) 
H80Q 
H94Q 
H103Q 
H115Q 
H201Q 
H227Q 
H230Q 
H87Q 
H157Q 
H268Q 
H288Q 
H527Q 
H534Q 
H554Q 
H579Q 
H580Q 
H639Q 
2.7 ± 0.1 
12.1 ± 0.2 
2.4 ± 0.1 
0.70 ± 0.06 
2.0 ± 0.1 
0.60 ± 0.02 
1.6 ± 0.1 
27.3 ± 0.03 
9.3 ± 0.1 
0.6 ± 0.09 
0.1 ± 0.03 
0 
0 
0 
0 
6.9 ± 2.7 
3.8 ± 0.04 
6.7±0.2 
23.2±0.4 
11.1±0.3 
1.3±0.1 
6.6±0.02 
3.1±0.1 
7.7±0.4 
38.1±0.4 
11±0.3 
1.7±0.1 
3.1±2.7 
0 
0 
0 
0 
17.1±0.6 
6.4±0.1 
0.40 
0.52 
0.22 
0.54 
0.29 
0.19 
0.21 
0.72 
0.85 
0.35 
0.03 
0.00 
0.00 
0.00 
0.00 
0.40 
0.59 
eEF-2K G6 38.4±0.9 35.0 ± 1.4 1.10 
To test which histidine mutants could be contributing to eEF-2K activity under low pH, various 
eEF-2K histidine to glutamine mutants were screened. The rates under the conditions pH 6.2 
(using Bis-Tris) in the absence of calcium and pH 7.5 (using HEPES) in the presence of calcium 
were measured to look at the ability of the mutant to retain activity under low pH and to verify 
the mutant had activity under standard conditions, respectively. 2 nM enzyme, 50 nM CaM, 150 
µM substrate peptide and either 10 mM EGTA (pH 6.2) or 50µM free calcium (pH 7.5) were 
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incubated in reaction buffer (Buffer 5.A) before initiating substrate phosphorylation with 1mM γ-
32P-ATP. Phosphate incorporation was measured over time and the corresponding slope for each 
enzyme is reported above as the observed rate (Vobs). The mutants were expressed using the G6 
eEF-2K variant, which is an eEF-2K without a regulatory loop. This non-mutated eEF-2K G6 
enzyme was used for comparison observed rates were also determined using 50 nM CaM; lower 
CaM was used for the mutants to ensure that saturation was not masking any minor fluctuations 
in kinetic behavior do to a mutation. To determine which mutants to further characterize, the ratio 
between Vobs of pH 6.2 in the absence of Ca2+ (where a histidine residue could potentially be 
critical) and pH 7.5 in the presence of Ca2+ (where the activity of the enzyme should be optimal) 
was calculated and compared to eEF-2K G6 (ratio of 1.10). We selected mutants with greater 
than a three-fold difference in ratio (ratio < 0.34) to study further (yellow highlighted mutants). 
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Mutant 𝐕𝐦𝐚𝐱𝐚𝐩𝐩 (s-1) 𝐊𝐂𝐚𝐌𝐚𝐩𝐩  (nM) 
H103Q 
H201Q 
H227Q 
H230Q 
H288Q 
G6-eEF-2K 
4.0 ± 0.2 
1.1 ±0.03 
1.0 ±0 .2 
1.0 ± 0.1 
n/a 
41.8 ± 0.8 
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Figure 5.1. Characterization of the CaM dependence of select eEF-2K histidine 
mutants.  
(A-F) The following histidine mutants with a two-fold difference in pH 6.2 – Ca2+ : pH 
7.5 + Ca2+ ratio from G6-eEF-2K were selected for further characterization: H103Q, 
H201Q, H227Q, H230Q, H288Q. 2 mM of each mutant was incubated with various CaM 
concentrations (0, 1, 5, 10, 25, 50, 250, 500, 1000 nM), 1 mM EGTA and 150 µM 
substrate peptide at 27°C in reaction buffer (Buffer 5.A, Bis-Tris) at pH 6.2 before 
substrate phosphorylation was initiated with 1 mM γ-32P-ATP. Each CaM dose-response 
curve was performed in duplicate and the average rate (kobs) for each mutant was plotted against 
CaM concentration to determine maximum rate (𝑘!"#!"" ) and concentration of CaM at half max 
rate (𝐾!"#!""). (H) Depicts a summary table of the obtained kinetic parameters. (G) A plot of the 
CaM dependence curve for G6-eEF-2K eEF-2K at pH 6.2 in the absence of Ca2+ for comparison 
(as determined in Chapter 3).  
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 Figure 5.2. (See following page) 
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Figure 5.2. Model of the three-dimensional structure of eEF-2K.  
Model of the three dimensional structure of eEf-2K reported by our laboratory221. Green 
residues 103-330, Blue, residues 496-725.  
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Scheme 5.1. Illustration of histidine mutants on eEF-2K.  
Depiction of the structural layout and regulatory sites of eEF-2K based on various 
truncation studies and homology models48,53,54,57,58,172,201,202.  The highlighted domains 
include the proposed DXDXDG Ca2+-binding site (CRD, pink), the CaM-binding region 
(CBD, blue), the kinase catalytic domain and phosphate binding pocket (PBP) (green), 
the regulatory loop (R-loop) and associated phosphorylation sites, the degron motif (DM, 
lavender), and the C-terminal helical domain (SHR, yellow) containing three SEL1-like 
helical repeats required for eEF-2 binding. The residue numbers assigned are estimates 
based on previous experimental studies and the prediction software30,42,48.  Conserved 
histidine residues chosen for His to Gln mutations and their location in various domains 
are depicted in navy (17 total). 
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Chapter 6: Summary 
 
Previously, our laboratory discovered that at pH 7.5, eEF-2K is activated through 
a two-step mechanism, whereby Ca2+-CaM binding induces a conformational transition 
in eEF-2K to promote autophosphorylation on Thr-348.  These two steps are essential to 
achieve full activity towards a peptide substrate and continued CaM binding is essential 
to maintain eEF-2K activity.  In this dissertation I investigated the role of pH in the 
regulation of eEF-2K.  I discovered that eEF-2K activation and activity is acutely 
sensitive to a slight drop in pH and identified mechanisms contributing to this.   
I discovered that CaM can rapidly induce the activation of eEF-2K in the absence 
of Ca2+ ions at pH 6.2, whereas at pH 7.5 autophosphorylation is more than 50-fold 
slower. 
I found that in the presence of Ca2+ ions the maximal activity of eEF-2K towards 
a peptide substrate at pH 6.2 and pH 7.5 are comparable, demonstrating that pH has no 
effect on the intrinsic activity of the kinase.  However, I showed that in the absence of 
Ca2+ ions, H+ ions promote the binding of CaM to Thr-348-phosphorylated eEF-2K to 
stimulate its activity.  The half-maximal concentration of CaM required to maintain eEF-
2K activity at pH 6.2 in the absence of Ca2+ ions is 36 nM.  I also found that the maximal 
activity of eEF-2K at pH 6.2 in the absence of Ca2+ ions is comparable to the activity in 
the presence of Ca2+ ions, suggesting that CaM can adopt a similar active conformation in 
complex with eEF-2K in the presence and absence of Ca2+ ions. Notably, the pH-
dependence of the eEF-2K activity in the absence of Ca2+ ions was most consistent with 
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two independent protonation events occurring to promote the activity, with pKa’s around 
6.85.    
Interestingly, I found that in the presence of Ca2+ ions the binding of CaM 
appeared to be significantly tighter (< 0.5 nM) at pH 6.2 than in the absence of Ca2+ ions, 
suggesting that H+ and Ca2+ ions can promote CaM binding at least in part through 
distinct, complementary mechanisms.   
By following changes in fluorescence lifetime, I monitored CaM binding to 
eEF2K in the absence of Ca2+ ions. I found that CaM binds eEF-2K tightly at pH 6.2, but 
could not be detected at pH 7.5. The pH dependence of CaM binding was consistent with 
two independent protonation events occurring with pKa’s around 6.85, suggesting that 
CaM binding is acutely sensitive to a drop in pH. Taken together the data suggest that the 
pH-dependence of eEF-2K is largely related to the promotion of CaM binding by a 
decrease in pH. 
I examined the possibility that the pH-dependent binding of CaM was mediated, 
in part, by a histidine residue and looked for histidine residues whose mutation to 
glutamine more strongly impacted the activity of eEF-2K at pH6.2 in the absence of Ca2+, 
than at pH 7.5 in the presence of Ca2+.  Using a minimalized form of eEF-2K (lacking the 
N-terminus as well as the Regulatory loop), but which is still pH-sensitive I found three 
candidate histidines.  I found that that mutation of His-227, His-230 or His-288 that are 
found in the kinase domain, had a larger impact on the activity of eEF-2K at pH 6.2 in the 
absence of Ca2+ ions than at pH 7.5 in the presence of Ca2+ ions. Introduction of the 
H227Q or H230Q mutants resulted in a significant increase in Km (CaM) at pH 6.2 in the 
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absence of Ca2+. These data support the notion that protonation of H227 or H230 support 
the activity at pH6.2. Further studies are needed to examine the pH dependence of the 
structure and activity of these mutants.  
In summary, the studies in this dissertation lay the foundation for future 
structure/activity studies to reveal the molecular basis for how low pH regulates the 
activity of eEF-2K. My studies support the notion that eEF-2K is acutely activated by 
slight drops in cellular pH, potentially providing a fast and reversible control mechanism 
for regulating the rates of protein synthesis.   
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Appendix 
 
A.1. LIST OF ABBREVIATIONS 
ADP Adenosine diphosphate 
AMPK AMP-activated protein kinase 
Apo-CaM Calcium -free form of calmodulin 
ATP Adenosine triphosphate 
APK Atypical protein kinase 
Ca2+ Calcium 
[Ca2+]free Free calcium concentration 
CaM Calmodulin 
CaM(C75)IAE Calmodulin where the IAEDANS label is attached to Cys-75 
CaMK Calcium/calmodulin-dependent protein kinase 
cAMP Cyclic adenosine monophosphate 
CDK1 Cyclin-dependent kinase 1 
CDK2 Cyclin-dependent kinase 2 
DTT Dithiothreitol 
EDTA Ethylenediaminetetraacetic acid 
eEF-1a Elongation factor-1 alpha 
eEF-2 Eukaryotic elongation factor 2 
eEF-2K Eukaryotic elongation factor 2 kinase 
eEF-3 Elongation factor-3 
EGTA Ethylene glycol tetraacetic acid 
ERK Extracellular-signal-regulated kinases 
FPLC Fast performance liquid chromatography 
(G-D-I)-eEF-2K Recombinant human eEF-2K preceded by three residues 
(Gly-Asp-Ile) – a remnant of the Trx-His6-tag after cleavage 
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GTP Guanosine triphosphate 
HAK Heart alpha-kinase 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC High-performance liquid chromatography 
i-CaM Calmodulin where the IAEDANS label is attached to Cys-75 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
IRES Internal ribosome entry site 
 Apparent catalytic constant 
 
Apparent rate constant 
 Apparent substrate concentration required to achieve half 
maximal activity 
 Apparent MgATP concentration required to achieve half 
maximal activity  
 
Apparent co-activator concentration required to achieve half 
maximal activity 
 Dissociation constant 
 
Dissociation rate 
 
Association rate 
KAcO Potassium acetate 
K-type effect Effect due to a change in affinity 
MAK Muscle alpha-kinase 
MAPK Mitogen-activated protein kinase 
MAPKAP-K Mitogen-activated protein kinase-activated protein kinase 
MEK MAPK/ERK kinase 
Mg2+ Magnesium 
MgATP Magnesium-bound ATP 
MHCK A Myosin II heavy chain kinase A 
app
catk
app
obsk
app
MK
app
aK
app
cK
dK
offk
onk
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MLCK Myosin light-chain kinase 
mTOR Mammalian target of rapamycin 
Ni-NTA Nickel-nitrilotriacetic acid 
PCR Polymerase chain reaction 
p-eEF-2KThr-348 eEF-2K autophosphorylated at Thr-348 
PKA cAMP-dependent protein kinase 
PP1 Protein phosphatase 1 
PP2A Protein phosphatase 2A 
PVDF Polyvinylidene fluoride 
p-WTThr-348 eEF-2K wild type autophosphorylated at Thr-348 
SCF Skp, Cullin, F-box containing complex 
SDS-PAGE 
TCSPC 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
Time-correlated single photon counting 
TBS Tris-buffered saline 
TBST Tris-buffered saline/Tween 20 
TEV Tobacco etch virus 
TPCK Tosyl phenylalanyl chloromethyl ketone 
TRPM6 Transient receptor potential cation channel, subfamily M, 
member 6 
TRPM7 Transient receptor potential cation channel, subfamily M, 
member 7 
Trx-His6-tag Thioredoxin-6xhistidine-tag 
T-type effect Effect due to a change in affinity by trapping calmodulin 
V-type effect Effect due to a change in catalytic rate 
 Apparent maximum velocity 
WT Wild type 
  
  
A.2. AUTHOR’S NOTE 
app
maxV
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A.2.1. MATERIALS AND METHODS 
Introduction. I recognize this is a nontraditional (nonexistent?) section to write, 
but it means so much to me that I thought I’d try and shove it at the end, anyway. The 
journey to earning this degree has been such a tremendous life experience. I’ve learned 
many things far beyond the bench and number crunching that it seems unfair to exclude 
purely on the grounds of professionalism. You’ve seen all the data and metrics and 
scientific findings that I’ve had to offer, and now I’d like to present my additional 
observations and hypotheses for the general pursuit of PhDs everywhere. I retained the 
“materials and methods” title of this section in the spirit of science, though I would like 
to add a disclaimer that these observations by no means follow the scientific method. For 
starters, I only have official records for n=1 (party of me).  
Pursuit of benefitting society. I initially wanted to pursue a PhD with an 
emphasis in cancer research because of the disease history of my family. There are few 
feelings worse than the one of being helpless. I knew on some level that I would probably 
be a cog in a machine, but in all of my naivety I was still set on making some sort of 
contribution regardless of how small. I wanted to learn about niche and novel research, 
contribute ideas. Unfortunately within my first year I was firmly disillusioned by 
bureaucracy, a trend that I saw among my classmates and senior students. Exactly how 
much research is noise in the void of a system that encourages sub-par work for the cycle 
of publishing and earning grants? What would a better system even look like?  
Pursuit of meaning. Another painfully common phenomenon among graduate 
students is imposter syndrome, which describes the potent sense of being inadequate and 
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out of depth. I have spoken to handfuls of people who have severely struggled with the 
sink-or-swim nature of starting grad school, which seems inefficient and unnecessary. 
Having this be a rite-of-passage, vetting or “well I did it too” occurrence seems a waste 
of resources, time and potential.  
Between the disillusionment of potential societal impact to my nearly debilitating 
imposter syndrome, I sought out another avenue to put my expertise to use. I found a 
fellowship that allowed me to visit primary school classrooms and explain their science 
topics in terms of active research. This was the most fulfilling experience of my PhD, but 
it was not easy to find or get into. The PhD was originally meant for people on a 
primarily academic track, but with supply far outnumbering demand for these positions 
this is no longer the case. Despite that most graduates go on to non-academic careers, 
PhD training has been slow to adapt and resistant to accommodating the modern needs of 
its students.  
 
A.2.2. Results and Discussion 
I have only seen the higher education academic system for 6 years (12 including 
pre-PhD work which I don’t). I am painfully aware that I have neither the experience nor 
reach necessary to truly impact such an old and traditional system. All I know is that 
there is room for improvement, and what I can do right now is express, debate and alter 
my observations and ideas with more experienced persons than I. As they are my ideas 
may be simplistic, but they are a starting point. I will summarize and bullet point four 
main calls for change.  
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The first is a stronger initial guidance and requirements. 
The second is about the physical and practical limitations of one person. When a 
university asks their faculty to mentor students, bring in grant funds, teach classes, run a 
lab and take on administrative or bureaucratic responsibilities, how can performance not 
be expected to suffer? As an aspiring educator, it is especially frustrating when this is 
reflected in undergraduate classes when students are turned off of a subject. 
The third I bring up because the climate is right. I’ll try to be brief. Are you 
treating male and female scientists equally? Everyone is here because of a passion for 
learning, a driving curiosity. Everyone made it to this point because they possessed a 
basic amount of capability that can be nurtured. If a woman starts wearing jeans in the lab 
instead of a skirt and leggings because she notices she is treated better in pants, that is an 
issue. If female scientists notice that they get stopped and corrected and questioned and 
talked over more frequently than their male counterparts, that is a problem. Looks, style, 
body parts, femininity, masculinity, mannerisms, and personality presentation have no 
bearing on scientific or intellectual capability. That fact needs to be reflected in the 
treatment of people.  
Lastly, and probably most critically, is the need for PhD programs to have more 
out-of-academia experiences and skill training. Research grants are currently and 
primarily meant to fund lab studies, results, and data. We are oversaturated in graduate 
students and postdoctoral positions. What would it look like if graduate programs paired 
with companies and agencies so that students spent part of their time in the lab working 
out a dissertation and part of their time in relevant career training? A few hours a week 
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teaching in a classroom, helping out in a policy maker’s office, interning for technical 
writers? Is that really too far out of reach? 
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